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While starting thesis research I have crossed over the problems of identifying the main aims and 
objectives of my thesis, as well as the need of its further implementation. That is why my first 
step towards helding a research is define main problems of the thesis and the harmonogram for 
my future investigation.  
Firstly, I have found out, that there is a lot of information about cancer deseases and 
mortality from cancer in the Internet and other available sources, but that information is kind of 
descriptional, moreover including the personal meaning of its authors. My thesis will be 
objective and based on the relevant sources of information. There are no personal (subjective) 
judgements and opinions, but descriptive analysis of the current staff and my analysis of its 
development for the selected period (based on statistical information and analysis as well). Thus 
I can proclaim that this thesis is my own research combining already existed data and 
information about thesis, but completed and added with the practical analysis, calculations and 
graphic depiction.  
Introduction part is one of the main parts of the thesis, as it defines further scheme of 
investigations. I have devided my introduction on several parts. In the first part of the thesis the 
basic analysis of the researched questions will be performed. There is given an overall 
introduction to the probematics. In the second part the goals and targets of the thesis are 
indentified. In the third part I will show subsequently the practical relevance of the work. Thus I 
have all of the necessary point: problem definition, research scheme and practical 
implementation of the following text.  
1.1 Problem definition 
Cancer deseases are commonly called as the “plague of the twentieth century”. Cancer causes 
many deaths, and it is not the problem of only aged people, but young patients and children as 
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well. The cruelty and fatality of this problem is that cancer is still not completely curable, there 
is no universal medicine or method how to eliminate it or to diminish this process.  
The tendencies and prospects have been studied by a lot of scientists and professionals; 
various of methods have been created and patented and there are also measures how to prevent 
oneself from cancer deseases – however all of those methods are just pathetic. I can assume that 
medicine sciences and laboratory research have caused great improvement – now sick people 
can diagnostify this desease in its early stage, thus assure themselves from inevitable death, but 
still the procedures are optional, so not everybody may underdergo it and are aware of the 
desease when it is already too late… 
In general we are able to say that cancer is the uncontrolled proliferation of any particular 
group of cells. If the cells start dividing and growing uncontrollably, there will be a failure of 
their DNA. As a result, cells are suppressed in the vicinity. Over time, these cells can penetrate 
into the bloodstream through which it spreads to other parts of the body. The body begins to 
lose nutrients and then its inventory will be depleted. In the final phase these uncontrolled 
spreading cells kill their individual. (Lecba-rakoviny.cz 2012). 
Preventive action should constitute a significant part of clinical practice, which was carried 
out either on the individual patient or on the level of the whole company. Each of us will 
appreciate very much if we can avoid certain types of illness through the intervention of 
doctors, or they will be taken at such stage, which will not require difficult and burdensome 
treatment yet. A few important facts about cancer (World Health Organisation, 2004): 
 Cancer is the second leading cause of death (adults have immediately after cardiac 
and vascular diseases, children have immediately after accidents). 
 At present it is known that every third person in his live will fall ill with cancer. 
 Between 5 and 70 year of life increases the risk of cancer in proportion to the age. 
 Cancer is more common disease among men, and this is probably related to their 
lower immunity and riskier lifestyle. 
 The most common influenced cause of cancer is nutrition, but now in the second 
place there is smoking. 
The vast majority of cancer has certainly a genetic basis, which is manifested as a 
prerequisite for a particular type of cancer. This assumption may not occur in life at all, but 
often it occurs. This happens especially in a situation when this desease is combined with 
certain risk factors. (Lecba-rakoviny.cz 2012) 
As time passes and oncological deseases are part of people everydays life (as we hear about 
them in mass media, from our friends and members of the family), there have started several 
mass marches and activities which offer to everybody free diagnostics of the whole medical 
staff and elimination of cancer deseases at its beginning. I can give an example of “AVON 
march against breast cancer” (Zdravaprsa.cz 2012), charity activity “Movember against cancer” 
(Praha-tip.cz 2011) and other mass activities and charity actions. This shows on the actuality of 
the problem and the need of its solution via medicins, preliminary observations and 
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diagnosifications, but first of all, in the legal frame for all inhabitants of the Universe to make 
cancer preliminary maintenance visits obligatory, not optional.  
1.2 Research goals and objectives 
The goal of this thesis is to estimate the current cancer mortality rates in Kazakhstan, using the 
most accurate available cancer information, through detailed descriptive analysis of cancer 
mortality changes observed in comparison with some selected European countries, during the 
period 1986–2008. In order to achieve this, several objectives are summarized in this thesis: 
- to analyse all-cause mortality patterns in Kazakhstan including their cause–of–death 
components in comparison with some selected European countries; 
- to discuss an investigation of the quality of the different cancer mortality data sets, and 
in particular, how representative they are of the overall Kazakh population; 
- to describe a review of cancer mortality time trends, including differences in trends by 
sex, age group, site and speculating on the possible reasons; 
- to analyse the estimation of standardised mortality rates of different cancer sites. 
1.3 Cognitive and practical relevance of the theme 
Studies on cancer mortality have been conducted for almost all of European countries, also a 
few for Kazakhstan. Notably after Kazakhstan got independence in 1991, differences among 
countries of USSR, one of them being Kazakhstan, were not compared to European countries.  
Within Europe there is not only a cancer mortality gradient between the East and West, but 
also between the North and South. Mortality, caused by some specific malignant neoplasm in 
Kazakhstan is in the highest level among selected European countries. Not only is life 
expectancy low, but also other demographic factors showing unfavorable trends. 
Analysis of cancer mortality in Kazakhstan is of specific scientific interest. First of all, since 
taking independence Kazakhstan has undergone an enormous socio–economic transition and 
has also experienced an important change in mortality. In general, the mortality gap between 
Kazakhstan and some selected European countries has diminished in specific death rates. 
Second, it is worth examining why Kazakhstan is on the lower end of the range among the 
mentioned countries. Surprisingly little research has been devoted to this topic recently. This 
study aims to fill this gap. 
The scientific novelty of this thesis and its theme is given by the above–mentioned fact that 
in depth analysis of cancer mortality development in Kazakhstan is almost completely missing 
in scientific literature. Several aspects of cancer mortality analysis presented in this thesis are 
very probably studied and presented for the first time in the given spatial and historical 
framework. 
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1.4 Structure of the thesis  
After discovering of all mentioned problems and hypothesis I have created a relevant structure 
for my master thesis. First part is a theoretical part – here I carry out literary research of the 
topic trying to find the most relevant and appropriate literature (books, monographies, articles 
and chapters) of the cancer problematic in the world, particularly in the member states and in 
Kazakhstan. Primarily those are statistical and demographical reviews which are described in 
the text below. It is necessary to start with demographic chapter as it describes the “content” of 
the particular states and main tendencies in the recent years (migration, people movements etc.).  
After discovering the main topic and its theoretical background it is necessary to underline 
this theory with practice and analysis. Thus the second part of the thesis is dedicated to practical 
implementation, charts presentation and description of statistical analysis.  
The conclusion part is a final outcome of the whole research. Conclusion includes not only 
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2.1 Review of the literature 
Europeans today enjoy healthier, wealthier and longer lives than ever, a great achievement of 
our societies. However, policy–makers are still facing major health challenges, such as 
widening health gaps between and within member states, ageing of the population and 
increasing levels of chronic disease, including cancer. 
Cancer, this complex group of diseases with serious implications not just for individuals and 
their families, but also for society in general and health systems in particular, remains an 
important health challenge in Kazakhstan, in Europe and world–wide.  
At present, with more than 3 million new cases and 1.7 million deaths each year, cancer 
represents the second most important cause of death and morbidity in Europe. If these data are 
linked to the data on the projection of the burden caused by other non–communicable chronic 
diseases and to the data on the ageing of the European population, the problem is seen to be 
even greater. Without effective interventions, the cancer burden will increase dramatically, but 
comprehensive cancer prevention and control policies can bring significant benefits. (Global 
health risks 2011) 
The text above shows the scale of the problem, which must have reflection in the scientific 
and literature world, describing different aspects of cancer deseases, psychological, sociological 
and demographical impact on one’s life.  
Unfavorable mortality trends in the former Soviet republics have attracted the attention of 
many researchers. The increase in mortality observed in the former USSR, and, after its 
collapse, in the New Independent States (NIS), represents a trend that is unprecedented in 
peacetime, and has thus stimulated extensive research. As a result, several kinds of explanations 
for the recent mortality crisis have been proposed, each tending to complement rather than 
contradict the others.  
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The most straightforward, widespread, and well documented of them is that excessive 
alcohol consumption has had a strong influence on life expectancy at birth (Anderson and Silver 
1990; Mesle´ et al. 1992; Shkolnikov and Nemtsov 1997; Shkolnikov et al. 1998). Alcohol is 
known to be directly associated not only with violent mortality, but also with other causes of 
death. Research has demonstrated that heavy alcohol consumption has been an important 
determinant of cardiovascular mortality in the region (McKee and Britton 1998; Malyutina et al. 
2002).  
However, while alcohol plays an important role as both an immediate and an intermediate 
mortality determinant, it is far from being the only driver of the recent health crisis.  
There are additional explanations linked to the abrupt political changes that triggered a very 
severe socioeconomic crisis (Mesle´ et al. 2000, 2003). Unemployment growth, the erosion of 
the social security system and of the health sector, falling living standards, and growing income 
inequality are viewed as determinants of psychological stress and unhealthy behavioral patterns, 
which in turn have a negative impact on the health status of the population (Bobak et al. 2000; 
Cockerham et al. 2006; Cornia and Paniccia 2000).  
Other theories regarding the mortality crisis, such as declining standards of medical care and 
changes in dietary habits, have not received substantial support (Brainerd and Cutler 2005). 
Furthermore, the recent negative mortality dynamics cannot be fully attributed to the above-
mentioned factors only. 
First, the health crisis in the former Soviet republics is known to be the long-standing; it 
emerged well before the collapse of the USSR (Eberstadt 1981; Feshbach 1984; McKee 2006). 
Until the early 1960s, life expectancy at birth in the USSR was growing and catching up 
with that of the Western world. The Soviet health care system was very successful in combating 
infectious diseases, but less effective against non-communicable diseases. In particular, unlike 
Western countries, the Soviet Union failed to benefit from the ‘cardiovascular revolution’ (i.e., 
the steady reduction in cardiovascular mortality, which was unanticipated and revolutionary 
from the viewpoint of the classical theory of epidemiologic transition; Omran 1971).  
In the mid-1960s, cardiovascular diseases became the major cause of death, and mortality 
from accidents and other external causes was unusually high. From that time onwards, the 
USSR experienced a dramatic reversal on the path toward declining mortality, a trend which 
was especially pronounced in working-age men. Second, mortality trends in the early 1990s 
might have still been affected by the inverse effect of the anti-alcohol campaign launched by the 
Soviet government in 1985.  
To sum up, the literature suggests that the mortality trends in the region seem to be 
influenced by the interplay of three major factors: the long–standing health crisis that began in 
the USSR several decades ago, the effects of the anti–alcohol campaign, and the socioeconomic 
and political changes that emerged with the dissolution of the USSR. 
Our study focuses on the divergence in the recent mortality trends in the countries of the 
European Union in comparison with Kazakhstan and the Russian Federation as a country of the 
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former USSR. To explore the potential mechanisms of such a divergence, we purposely selected 
very contrasting cases in terms of the recent socioeconomic and demographic developments. 
Before the dissolution of the Soviet Union, Kazakhstan and the Russian Federation were 
quite comparable in terms of economic performance and living standards. Despite some 
differences in overall mortality levels, they were also very close to each other in terms of 
directions of mortality trends and age–specific and cause–specific mortality patterns. After 
1991, Kazakhstan and the Russian Federation experienced substantial political and social 
transformations, and faced multiple challenges associated with the transition from a socialist to 
a market economy system.  
The sudden changes brought numerous problems, such as unemployment, falling living 
standards, a rise in poverty, and socioeconomic differentiation. These factors contributed to the 
significant deterioration in the already poor health situation (Cockerham 1997), but their 
magnitude and impact on the mortality crisis differed from country to country. 
2.2 Description of the demographic situation in the selected 
countries 
Figure 1 (see below) shows to us immigration of people to 8 countries in period from 1998 till 
2008. The highest immigration during those 10 years was to Italy. Not dynamically developing 
high-tech sector generates massive outflow of intellectual capital of Italy. Young scientists, high 
school graduates leave the country in search of opportunities to continue the scientific activities 
in more favorable terms.  
It should be noted that the level of immigration and post-graduate students is much higher 
than the national average. At the same time in Italy, a flood of migrants from developing 
countries. The geographical position of Italy is that it is located on the southern border of 
Europe, which leads to relatively high levels of migration from African countries. Also, the 
influx of immigrants comes from Asia, particularly China.  
Immigrants from these regions are willing to work for lower wages than the indigenous 
population. This raises the issue of displacement of the indigenous population of cheap foreign 
labor. A significant portion of foreigners arriving in the country illegally overstates the official 
statistics on unemployment.  
At the same figure we can see that the smallest amount of immigrants coming to France.  
The convenient geographical location, the presence of many international flights of air, sea, and 
rail and road modes of transport, a high standard of living in France is attractive to immigrants 
from Asia and the Middle East, Africa and European countries with unstable ethno-political 
situation, or have difficulty economic nature, including the Russian Federation, other CIS and 
Baltic republics.  
As a result, while other countries are characterized by high birth rates and emigration, 
France has been for over 150 years of hosting foreigners, thus striving to resist the natural 
19 
Askhat Ashimov: Trends and patterns of cancer mortality in Kazakhstan in comparison with 
some selected European countries from 1986 to 2008 
decline of its population. Indeed, many experts agree that France needed immigrants. Another 
four countries which were mentioned in the figure 1 have stable level of immigration around 
50 000 people per year.  
The dynamics of inter-republic and international migration has tended to picking up the 
Kazakh ethnic group in the country of the same name and the return of other ethnic groups more 
often in place of the original release. There was a reduction of immigration flows to Kazakhstan 
and the intensification of the outflow of population from Kazakhstan. Some growth of 
repatriates was observed in Kazakhstan in 2004-2005 by Kazakhs from abroad - from 
Mongolia, China, Iran and Afghanistan (Asylbekov and Kozina 1995). 
The main immigration flows to Kazakhstan were immigrants from Russia, Uzbekistan, 
Turkmenistan and Kyrgyzstan. Gained considerable scale and illegal immigration. Although the 
law restricts the import of Kazakh workers in Kazakhstan, the scale of illegal labor is enormous. 
The main flow of illegal workers is coming from Uzbekistan, Kyrgyzstan and Tajikistan. 
Cotton, tobacco, and other technical labor-intensive crops in the present scale, construction and 
material handling are ensured due to the influx of cheap foreign labor.  
The mass deportations of illegal immigrants from Kazakhstan have not led to a marked 
increase in local employment. This involvement in the sectors with "dirty" technology, heavy 
physical manual labor monotonous seasonal workers from neighboring countries. Free hire 
cheap labor, not only releases of these areas, local workers, but also contributes to the 
acceleration of urbanization in rural areas (Asylbekov and Kozina 1995). 
There is a spillover of the local workforce in the industrial sector, in education, science, and 
qualified domestic service, information technology and creative niche. Part of the rural youth is 
leaving to study in the city. There is a serious expansion of migration from Uzbekistan, 
Tajikistan and Kyrgyzstan to Kazakhstan, can seriously deteriorate the quality of labor, social 
and hygienic environment, and crime. 
If in the first half of the 1990s among the illegal immigrants dominated the citizens of 
China, in the second half of the 1990s - the citizens of Turkey. In 1999-2000, marked by 
particularly sharp rise in illegal immigration (transit) from Afghanistan and Sri Lanka, which 
was associated with a worsening political situation in these countries. Difficulties experienced 
adaptation and refugees who came from the "hot spots". Accounting for those wishing to take an 
official status, leads Agency for Migration and demography. In 2001, Kazakhstan was officially 
registered more than 900 refugees; the real figure is around 20,000 (Kozina 2000). 
20 
Askhat Ashimov: Trends and patterns of cancer mortality in Kazakhstan in comparison with 
some selected European countries from 1986 to 2008 
Fig. 1. Immigration in the selected countries 1998-2008  
 
Source: Author’s own calculations based on data EUROSTAT database 
Figure 2 shows emigration rates of 8 countries from 1999 till 2008 year. Values are in 
thousands of people. According to that figure the most high emigration trend shows Russia. 
Emigration of people started from 1999 year, it can be suggested because of unstable 
economical situation of country and monetary default in 1998. This process is accompanied by 
the flows of the capital and assets from the Russian Federation, and thus the inhabitants moved 
to the places they invested to or they were associating their economic life.   
From 2004 we can see the sharp rise of emigration rate. At 2007 seemed very small flow of 
emigration. Looking to other countries: Sweden, Italy, Hungary, Norway; we can see a stable 
emigration rate of people. This amount is about 70 000 people per year. Probably it can be 
explained by favorable economic prosperity. On the figure 2 we can see that emigration line of 
France is different from other European countries.  
Emigration is started at 2003 and was higher than in other describing countries. The last 
country which is described on that graph is Kazakhstan. According to graph we can see that 
emigration in Kazakhstan started at 2003 and was going a little bit lower till 2006 and than it 
returned to the same level. Since 1991, the population is constantly decreasing due to declining 
fertility, reduction in life expectancy at birth, particularly among men, and emigration (Kozina 
2000). 
The flow of emigration has decreased from 309.632 persons in 2001 to 65.785 in 2004 with 
the same direction as the movement of immigrants - other CIS countries, especially the Russian 
Federation (66.6%) as the destination. Moreover, the main outflow of the population comes 
from the regions bordering with Russia (Eurostat 2011). 
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 City dwellers have higher qualifications and it is easier to get a job in another 
country. 
 In the village live mostly people of Kazakh nationality. To migrate to Russia or to 
other countries it is more complicated. 
 The village is much poorer than the city on the move requires considerable 
resources. 
 The migration processes that have been taken place, and having in Kazakhstan, had 
their impact on the demographic situation in the country.  
 Emigration from Kazakhstan is different. This is actually irreversible "brain drain 
and qualifications". Much of the emigrants are trained staffs, who are leaving with 
families forever. 
Another stream of emigration is young people, departing to study in Russia. This stream is 
not defined ethnic groups. According to a survey in the border regions with Russia, many 
children learn in high schools in Omsk, Novosibirsk, and Tomsk.  
The probability of their return to Kazakhstan is extremely low. It is possible that emigration 
to the study may not register with the state authorities, as those who leave are not officially 
required to declare to anyone about leaving. Currently, immigration sentiment Slavic ethnic 
group again increased. This is due to several factors. (Kozina 2000): 
 Revolution at the nearest neighbor - Kyrgyzstan; 
 May conflict of opposition and young people in Chimkent; 
 Persistent, albeit slow implementation of the official language in administrative 
procedures; 
 Having grown up home prices in the major cities, which allow you to purchase 
accommodation in Russia by selling available in Kazakhstan. 
 It is possible that the outflow skilled manpower from Kazakhstan will continue. 
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Fig. 2. Emigration in the selected countries 1999-2008 
 
Sources: Author’s own calculations based on data from EUROSTAT database  
This item represented fertility is an average number of births per woman of reproductive 
age. The fertility rate is a more accurate indicator of fertility than the crude birth rate. This ratio 
indicates a potential change in the structure of the population in the country. The fertility rate 
two children per woman are considered as the breeding ratio. The fertility rate for more than 
two children per woman contributes to the growth of the population, while the median age is 
lowered.  
An even greater fertility rate indicates that parents may have problems with how to feed and 
educate their children, and women may appear difficulties with access to work. The fertility rate 
less than two children per woman help to reduce the number of population and it’s aging. 
Globally, fertility rates decline. Most of these trends can be seen in industrialized countries, 
particularly in Western Europe, where in the next 50 years a sharp reduction in the population is 
not anticipated.  
Parents prefer to have less children, if the overall quality of life improves and they do not 
have to be afraid of high infant mortality. It should be noted that the rapid decrease in fertility 
may not lead to lower birth rates in the country, if the composition of the population, the 
proportion of young families. Countries with high-income population growth are even slower.  
For today's developed countries are characterized by the so-called aging of the population. 
As a result of low fertility in these countries, combined with a paradoxical at first sight, is an 
increase in mortality. In developed countries such as Germany and Italy, these trends have led to 
an absolute reduction in population due to its "natural wastage". In the future, demographers 
expect the spread of the situation in other developed countries.  
The birth rate in European countries with economies in transition over the past 5-10 years 
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from the reasons for acting in most developing countries: most likely they belong to the so-
called social costs of transition. As a result, in Russia, for example, the level of fertility, it is an 
indicator of the number of children per average per woman, fell far below the "normal recovery" 
(a little more than two children per family), and below its rate in most developed countries. 
In 2009 totаl (births per woman) in Kаzаkhstan was 2.60, аccording to a World Bаnk report, 
published in 2010. 
Fig. 3. Number of children per woman in the selected countries 
 
Sources: Author’s own calculations based on data from EUROSTAT database 
On the predication of the World Health Organization after 60 years of old age begins. The 
elderly, mind you, but not senile. Here in the figure 4, 5 we will show the rate of life expectancy 
after 65 years, on period of retirement age.  
Over the past five decades in the European Union both women and men about 10 years, 
increased life expectancy at birth. By 2008 it reached 82.4 years and 76.4 years respectively. 
Increased life expectancy has occurred in all EU countries.  In 2008, the largest women's life 
expectancy at birth was observed in France (84.8), Italy (84.2 according to 2007) and Sweden 
(83.2) in men - in Sweden (79.1), Italy (78.7 - according to 2007), and the Czech Republic 
(74.1). 
Upon reaching the age of 65 EU women can expect another 20.7 years, survival, men - 17.2 
years. As life expectancy at birth for the period 1999 – 2008, life expectancy of 65 years also 
increased in all EU countries. The largest of its growth for both women (23.0) and men (18.5) 
was recorded in France.  
Scientists have analyzed the performance in the EU and in Russia and came to the 
conclusion that as a cause of premature death, comparable only to infectious diseases and 
cancer, although of them in Russia die more often, but not significantly. Around the same time 
most Russians have become victims of poisoning, crime and traffic accidents. The probability of 
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Today Kazakhstan and EU countries are confronted with complex demographic problems. 
Europeans began to live much further due to the good health and quality of life. However, 
simultaneously with the increase in life expectancy is reduced fertility in Europe. This will 
inevitably lead to a reduction in the number of employees. In the future, society will not be able 
to provide the European retirees familiar, relatively high pensions.  
Fig. 4: Development of life expectancy at age 65, in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Fig. 5: Development of life expectancy at age 65, in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Figure 4 and 5 show the average life expectancy of the male and female population over 65 
years, supremely these countries during the period 1986-2008, respectively. On the base of that 
graph ve can observed that on countries: Norway, Italy, Sweden, France life expectancy after 65 
years clearly exceeds the life expectancy after 65 years of men at countries: Kazakhstan, Czech 
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Chapter 3 
Theoretical and empirical framework 
3.1 Basic concepts and terminology 
The used basic terms and concepts applied in thesis. Mortality is the condition or quality of 
being mortal; subjection to death or to the necessity of dying. (Webster 1913)  
Life expectancy is the expected (in the statistical sense) number of years of life remaining at a 
given age. 
Age standardized rate is defined as a method of adjusting the crude rate to eliminate the 
effect of differences in population age structures when comparing crude rates for different 
periods of time, different geographic areas and/or different population sub–groups (e.g. between 
one year and the next and/or States and Territories, Indigenous and non–Indigenous 
populations). Adjustments are usually undertaken for each of the comparison populations 
against a standard population (rather than adjusting one population to resemble another). 
Sometimes a comparison population is referred to as a study population. 
Ageing index is calculated as the number of persons 60 years old or over per hundred 
persons under age 15.  
The potential years of life lost (YPLL) for each death (usually to residents of a geographic 
area for a specific time period) are summed to represent the total years of potential life lost for 
that area.  
Standard populations are “artificial populations” with fictitious age structures that are used 
in age standardization as uniform basis calculation of measures for the respective reference 
population. 
Cancer can affect virtually any organ, but almost all types of malignancy share a common 
feature–the capacity of the cells to multiply without control, to spread to other organs 
(metastasise) and to kill the patient. The suffering of cancer patients and their families at an 
individual level is mirrored at the societal level, creating a huge burden for health services and 
the wider economy (Brown et al. 2001). 
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But the term “cancer” is not used just once. There are a lot of kinds of cancer – more than 
100, that is why this term is used for different deseases, but with same roots. In this case we are 
able to talk about cancer of stomach, mouth, lung, cancer of breast, sarcoma of bone, prostate, 
and Hodgkin disease, cancer of cervix, colon/rectum, non–Hodgkin lymphoma and leukemia. In 
all these desease common is the failure of the mechanisms, which control and regulate normal 
growth of cells, its proliferation and its death. 
According to statistics 65% of patients, who were given a diagnose of cancer, are people of 
the elderly population of over 65 years. In 2008 of the 12.4 million of new cancer cases in the 
world, the most popular were lung cancer (1.52 million), breast cancer (1.29 million), and 
colorectal cancer (1.15 million). 
It is very important to understand that 40% of all cancer cases it is possible to prevent in 
case of not smoking, eating a healthy diet and by taking physical exercise.  The usage of 
tobacco is a very strong factor for everybody to possibility of having cancer in many different 
types of cancer such as: stomach, kidney, lung, and bladder, and throat, mouth, liver and 
pancreatic. Lung cancer is most of all the result of active or passive smoking. But also there is 
another example of possibility to have lung cancer is an environmental tobacco smoke. 
The same catastrophic results are in countries with developed economy and science, because 
of factors as smoking, unhealthy diet and inactive lifestyle, which give rise to cancer 
appearance. For example, such sickness as obesity is associated with breast cancer, kidney, 
uterine, colon, and esophageal cancer. There a lot of kinds of cancer, but some of them are the 
result of infection or biological carcinogens. For example, it can be caused by parasites (bladder 
cancer and schistosomiasis cancer), viruses (human papillomavirus (HPV), cervical cancer, 
hepatitis B and C, and liver cancer) and bacteria (gastric cancer and Helicobacter pylori cancer). 
But not only the usage of tobacco gives rise to cancer, but also excessive alcohol 
consumption is a result of such types of cancer as head and neck, esophageal, throat, liver and 
breast cancer. 
Medical treat in case of cancer deseas is very important, because if person does not have any 
medical treat and regular control, cancer cells will penetrate into nearest tissue and diffuse to 
other parts of the body through the lymphatic system and bloodstream. The case, which was 
described above, is called metastasis of cancer, and only this factor makes this desease so 
deadly, because it is very difficult and sometimes impossible to stop penetration and diffusion 
of malignant tumors to other tissues in the body.  
But there are also benign tumors, which are slow growing and do not spread. Usually these 
tumors are innocuous if they do not influence on the function of nearest tissue. 
In the end I would like to summarize that cancer is not just a desease. It is a group of 
sickness, which could occur at any site in the body and could spread very fast. There are no 
limits in understandsing and controlling malignant disease, because of wide scientific 
knowledge and experience, which includes as individual choices and style of life as the 
complexities of intracellular molecular regulation. By the way to control planning, 
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implementing and evaluating disease strategies is very difficult, because of necessity of 
competent management and usage of the best available resources. Nowadays to prevent and 
control cancer is the most important topic in science and in the whole world. 
3.2 Relevant theories and facts 
Over the past centuries, mortality and morbidity patterns have been changing all over the world 
albeit with variations in timing and pace. These changes have been referred to as the 
epidemiologic transition.   
This chapter deals with a well-known theory, epidemiologic transition theory, which was 
chosen as the core theoretical model, in order to provide a comprehensive theoretical framework 
for the comparison of mortality. 
The epidemiologic transition theory provides a potentially powerful framework for the study 
of disease and mortality in populations, especially for the study of historical and international 
variations (Mackenbach 1993). Although its primary purpose was to describe and explain the 
spectacular fall in mortality which has occurred in all currently industrialized countries, it can 
also be used to speculate on the likely consequences of future changes in mortality in countries 
which are lagging behind those which have already completed the epidemiological transition 
(Beaglehole 1992). In addition this notion of a more or less fixed pattern of changes over time 
in cause specific mortality may lead us to interpret cross sectional differences between countries 
in cause specific mortality as being due to a different timing of the epidemiological transition, 
which in turn would suggest differences in stage of economic and social development as likely 
causes. 
The term epidemiologic transition refers to the shift in cause–of–death patterns that comes 
with the over–all decline of death rates. In European countries the fall in death rates, which 
began after the middle of the eighteenth century, came about because of a decline in infectious 
disease mortality (chiefly from cholera and tuberculosis). The victory over infectious diseases 
allowed people to live longer and hence to develop the chronic degenerative diseases that 
became the main causes of death during the twentieth century: heart disease, CVD, and 
malignant tumors. 
Before the eighteenth century the epidemiological pattern was far from stable but the shifts 
that occurred had no significant effect on the level of mortality. Some infectious diseases 
diminished in lethality, but other diseases replaced them. In 1960s it was thought that increases 
in life expectancy in the most advanced countries were nearing completion, but from the 1970s 
a major decline in CVD disease allowed new progress. Under the double effect of the 
continuation of the decline in infectious disease mortality, now largely eliminated, and the 
decline in CVD mortality, it is weight of mortality due to cancers that has been increasing. 
The epidemiological transition is one component of a series of concurrent changes in 
population health. Running parallel to it is a functional component, referring to change in 
functional health status of the population (that is, abilities and disabilities), and a gerontological  
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component, referring to the increasing proportion of the old and very old age groups in the 
population, with their distinctive health problems. The term health transition is used to describe 
these various components in combination. 
The transition is linked to improvements and advances in nutrition, hygiene and sanitation, 
and medical knowledge and technology. As such, the epidemiologic transition is related to the 
demographic transition and the nutrition transition, and is part of a more broadly defined health 
transition (Caldwell 2001). In addition to epidemiological changes or changes in health 
conditions, the health transition also incorporates related social changes such as a health care 
transition. The health care transition refers to the changes in the organized social response to the 
health needs of the population and deals with the way the health care system is organized to 
deliver its services. 
The characterization of long–run changes in cause of death as an epidemiological transition 
was first made by the public health physician Abdel R. Omran in 1971 in a paper that became a 
classic in the literature of public health. “During the transition”, Omran wrote, that there has 
been a change in the death deasease – reasons of mortality, as infections and pandemics have 
been replaces by genetic and degenerative deseases. (Omran 1971). Omran represents three 
stages:  
1. The stage before the transition – with average life expectancy of 20-40 years, caused by 
high mortality and fluctuations in population growth. The conditions for the life of 
individual are not proper, thus life expectancy at birth is very low.  
2. The transition stage, which is much more positive, than the previous one. The pandemia 
and fluctuations are rather rare, occasional, and they do not cause such great mortality. 
Thus birth rate is rising and other life indicators improve. Life expectancy is about 30-
50 years.  
3. The stage after the transition, when the main causes of mortality are of degenerativity, 
and thus population naturally grows. In this case natality is the main factor of 
population growth and it can strongly influence this indicator.  
Omran proposed three basic patterns of epidemiological transition: the classical (Western) 
pattern, the accelerated pattern (represented by Japan), and the contemporary or delayed pattern 
followed by most developing countries in Latin America, Africa, and Asia. He argued that the 
reduction of mortality during the nineteenth century in Western countries was determined 
primarily by ecobiologic and socioeconomic factors, the influence of medical factors being 
largely inadvertent until the twentieth century. 
What should be retained from this schematic picture formulated in the early 1970s? Not a 
lot, according to the demographer John C. Caldwell. In 2001 Caldwell wrote, “What happened 
in the mortality transition was the conquest of infectious disease, not a mysterious displacement 
of infection by degeneration as the cause of death. The resulting demographic transition with its 
changing age of death and the existence of large numbers of people afflicted with chronic 
degenerative disease (rather than life–threatening infectious disease) is important for planning 
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health services and medical training, which is the current focus of the burden of disease 
approach” (Caldwell 2001). Other criticisms of Omran’s account are that he suggested that the 
mortality decline would stop during the Age of Degenerative and Man–Made Diseases and that 
the epidemiological transition is universal, even if delayed for less–developed countries. 
In a later contribution to the subject, S. Jay Olshansky and A. Brain Ault described the third 
stage of the transition as a plateau in epidemiological history where mortality once again attains 
an equilibrium, with a life expectancy at birth reaching into the 70s. This value was believed in 
the 1970s to be close to the biological limit to the average length of human life.  
How long can this fourth stage of the epidemiological transition last? Olshansky and Ault 
inquired whether more debilitating conditions would replace heart disease and cancer as the 
main killers or whether people would die a non–disease–related "natural death" as James Fries 
suggested in 1980. But Olshansky and Ault contended that the shift to the fourth stage is the last 
of the transitions, given the likelihood that the human lifespan is finite (Olshansky and Ault 
1986). 
During the fourth stage proposed by Olshansky and Ault, the cause–of–death pattern 
continues to be modified because deaths are postponed toward older ages and the relative 
incidence of degenerative causes of death, cardiovascular diseases, and cancers varies by age. 
Thus the concept of a distinct fourth stage being added to Omran’s three stages is debatable. An 
alternative description would show a lengthened third stage characterized by shifting 
proportions of degenerative and human–made diseases, thus preserving a pattern of 
epidemiological transition with three “ages”. According to France Mesle and Jacques Vallin, 
however, this would not take into account the major epidemiological change represented by the 
“cardiovascular revolution” (Meslé and Vallin 2000). These authors divide the transitional stage 
into a first phase characterized by the decline in the infectious diseases and a second phase led 
by the decline in cardiovascular diseases, with possible additional phases to come. The study of 
mortality levels and cause-of-death patterns are of little practical help in assessing exact dates 
for the change from Omran’s second stage to his third stage (around the 1960s) and even less 
for dating the change from Omran’s third stage to the Olshansky and Ault’s fourth stage (around 
the 1970s). The number of years separating the second and the fourth stages appears to vary 
across countries. But in reality the cause-of-death pattern exhibits a more or less smooth 
modification over time rather than discontinuous change.   
According to Jean–Marie Robine, the study of the dispersion of individual lifespans 
provides support for the existence of only three stages (The epidemiologic transition theory. 
2001): 
1. The reference stage that precedes the fall in mortality–Omran’s Age of Pestilence and 
Famine–which came to an end during the eighteenth or nineteenth centuries, depending 
on the country. 
2. A first stage of transition, when the level of mortality fell and tended to stabilize as a 
consequence of the decline in infectious diseases affecting mainly children, resulting in 
a very large reduction in the disparities of individual lifespans around the mode. This 
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Age of Receding Pandemics came to an end in the 1950s in the countries that had gone 
furthest in the transition, such as northern and Western Europe, North America, and 
Japan. 
3. A new stage of transition (represented by these same regions) in which the mortality 
decline at adult ages, including the very old, becomes relatively larger than at younger 
ages and where the increase in life expectancy is no longer associated with a significant 
reduction in the dispersion of individual lifespans (Robine Jean–Marie 2001). 
This new stage corresponds less to Omran’s third stage–which in the early twenty–first 
century appears to have a weak empirical foundation–and more to the fourth stage proposed by 
Olshansky and Ault. It could be labeled the Age of the Conquest of the Extent of Life. This is 
the age when humans, having finally been liberated from the great epidemics, are increasingly 
able to experience the full extent of the potential duration of life. This stage too may eventually 
come to an end, perhaps to be succeeded by a further stage. Whether this will be the Age of 
Limits or something else is not known. But at present, in exploring their potential longevity, 
humans are making unexpected discoveries–such as finding that it is possible to live well 
beyond 100 years. 
For a period after World Wаr II, all developing countries seemed to be moving through an 
epidemiological transition; since the 1960s, that was no longer the cаse. Some countries, most 
notably those of Eastern Europe, failed to experience the cardiovascular revolution, thus 
deviating from the pattern described above. And a number of African countries, such as Nigeria, 
Zambia, and Zimbabwe, were struck by АIDS epidemics or by the resurgence of earlier 
diseases, without having completed the second stage of the transition. In the middle of the 
1960s, life expectancies in the countries of Eastern Europe and the Soviet Union (including 
Kаzakhstan) entered a period of stagnation or regression resulting from the combined effects of 
increased cardiovascular mortality, cancers, violence, and alcoholism. 
 
31 
Askhat Ashimov: Trends and patterns of cancer mortality in Kazakhstan in comparison with 
some selected European countries from 1986 to 2008 
Chapter 4 
Research questions and hypotheses  
4.1 Research questions 
The goal of this thesis is to estimate the current cancer mortality rates in Kazakhstan, using the 
most accurate available cancer information, through detailed descriptive analysis of cancer 
mortality changes observed in comparison with some selected European countries, during the 
period 1986–2008. In order to achieve this, several objectives are summarized in this thesis: 
 to analyse all-cause mortality patterns in Kazakhstan including their cause–of–death 
 components in comparison with some selected European countries; 
 to discuss an investigation of the quality of the different cancer mortality data sets; 
 to describe a review of cancer mortality time trends, including differences in trends 
by sex, age group, site and speculating on the possible reasons; 
 to analyse the estimation of standardised mortality rates of different cancer sites. 
4.2 Initial hypotheses 
The term “cancer” is commonly used to cover a wide range of diseases which all share a 
common feature, namely that cells in affected organs or tissues of the body (e.g. breast, lung, 
skin or bone marrow) continue to grow indefinitely, without reference to the needs of the body. 
Many cancers have the capacity to spread to other parts of the body and to kill the patient. 
With more than 3 million new cases and 1.7 million deaths each year (Ferlay et al. 2007) cancer 
currently represents the second most important cause of death and morbidity in Europe. 
Cancers have many causes. A few are the result of faulty genes; some are a consequence of 
an individual’s life history (e.g. how many children they have borne); some represent the 
longterm effects of exposure at any stage of life to cancer–causing agents such as tobacco 
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smoke; and many involve a combination of these factors. The cause or causes of many cancers 
remain unknown. Most cancers become much more common with advancing age. 
The total annual numbers of new cases and deaths (per 100.000 population) for all cancers 
combined vary as much as two–fold between Member States of the European Union (EU). The 
range of survival rates is similarly wide. For individual cancers, the variation across Europe is 
even greater.  
This reflects a wide range of social and epidemiological factors in Member States: cancer 
prevention programmes; screening programmes; cancer control plans; individual lifestyles and 
occupational exposures; the existence and accessibility of health–care facilities and 
technological infrastructure; and the availability of human, financial and material resources for 
health and economic development. 
Cancer is becoming an important public health problem in Asian countries with aging of 
populations and changes in lifestyles associated with economic development. Today cancer is 
the third leading cause of premature death in Kazakhstan. Every year approximately thirty 
thousand Kazakhstani people are diagnosed with cancer. This underlines the necessity on 
raising general awareness of the scope of the cancer problem in Kazakhstan. 
In the analyses of dynamics of cancer mortality the following four hypotheses will be tested: 
1. The annual rates of newly diagnosed deaths from cancer (mortality rates) are changing. 
Some cаncers (e.g. stomach cancer) are becoming less common, but others are increasing, such 
as malignant melanoma. The time trends in cancer risk also vary between European countries 
and some cancers show different trends between men and women, or young and old, or poor 
and rich. For instance, lung cancer rates are falling in many countries among men (particularly 
the more affluent groups) but increasing among women, particularly the young. In other 
countries, lung cancer rates are still increasing in both sexes. The pattern is similarly varied for 
many cancers, so the public health profile of cаncer in Europe is complex. Trends in the 
incidence and mortality rates are also influenced by successes in health promotion (e.g. tobacco 
control), efficient screening (e.g. breast, bowel, and cervix) and better treatment. These have 
been reflected in lower incidence, reduced mortality, higher survival, improved life expectancy 
and a better quality of life for cancer survivors. 
2. Cаncer mortаlity is more equally distributed across Kazakhstan. The rates in Kazakhstan 
are close to the average of European countries. However, as in other CIS countries with high 
mortality from other causes than cancer, the proportion of cancer deaths comprise about 12 % of 
total mortality in Kazakhstan, compared to a 28 % average of European countries with very low 
child and adult mortality, and since 1990 the rate has been steadily decreasing. During 1992–
2000 Kazakhstan experienced severe crisis after collapse of the Soviet Union. Cut in healthcare 
expenditure caused shortage of physicians, reduction of primary health care centers especially in 
rural area, and as a result access to the healthcare facilities for people was poor. We suppose 
that these factors could strongly affect the increase on cancer mortality in that period. Later, 
from 2001–2006 the situation in the country was more stable and new health care reforms were 
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implemented. Most possibly this could be the reason for the reduction of cancer mortality in a 
relatively short period. 
3. There are wide inequalities within Kazakhstan in terms of who gets cancer, and what 
happens to them when they do. People from deprived backgrounds are more likely to get some 
types of cancer and overall are more likely to die from it once they have been diagnosed. For 
several reasons, cancer patients in Kazakhstan have poorer survival than in other European 
countries. Although many cancer patients receive excellent treatment, services are patchy–
patients in different parts of the country receive varying quality and types of treatment. 
Experience of cancer care also varies, and long waits and uncertainty add to the inevitable 
anxiety of patients. 
4. The decreasing risk of dying from most forms of cancer in the European Union is a major 
success but does not allow any room for complacency. The disparity between the health status 
in the populations of Kazakhstan compared with these of northern, central and Eastern Europe 
requires significant and speedy remedial intervention. There is an urgent need to undertake 
research in central and eastern Europe to identify the causes of the excess cancer (and other 
chronic disease) mortality rates; to monitor through time changes in biomarkers of chronic 
disease in response to public health policy; and to create resources for capacity building in 
research and training of researchers in the whole of Europe. In addition, it is almost too late to 
take action to be in a position to cope with the increasing cancer burden which will arise 
throughout Europe due to the ageing population. 
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Chapter 5 
Data and methods  
5.1 Data availability and quality 
Mortality and mid-year population estimates data for calculating trends in cancer mortality in 
Kazakhstan and in selected European countries were taken from the World Health Organization 
Mortality Database (M–DB) (http://www.euro.who.int/en/home) For a review of selected 
socioeconomic characteristics, data from WHO European Health for All Database (HFA–DB) 
are used, which provide basic demographic and socioeconomic indicators, detailed indicators 
for study of mortality, morbidity, lifestyle, environmental quality, and quality health care. The 
data are available for all selected European countries, including CIS countries (Kazakhstan and 
the Russian Federation) for 1986–2008. (http://data.euro.who.int/hfamdb/). 
Eurostat database was also used to complete some missing population data 
(http://epp.eurostat.ec.europa.eu/portal/page/portal/eurostat/home/). Mid–year population was 
obtained by calculating the arithmetic mean of year x and year x+1. 
The study analyzed mortality data classified according to the abbreviated eighth, ninth and 
tenth revisions of the International Classification of Diseases. Data were obtained separately for 
males and females, by 5 year age-groups from age 0 to 85+. 
Before discussing the cancer profile in selected countries, it is helpful to consider the 
definitions of terms such as cancer mortality, as well as the sources of such information, their 
availability and, where necessary, their estimation. 
When estimating and projecting the cancer profile, chronological patterns in incidence or 
mortality rates depend not only upon the number of cases or deaths, but also on the quality of 
the denominators over time (Alderson 1981). 
Population-based cancer registries collect and classify information on all new incident cases 
of cancer in a defined population. They also provide statistics on incidence for the purposes of 
assessing and controlling the impact of cancer in the community. There are currently more than 
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170 cancer registries in Europe, covering national populations (e.g. the Nordic countries, the 
Czech Republic) or certain regions within a country (e.g. in Italy, France).  
The founding of cancer registries in Europe has occurred unsystematically over the last 
half–century, variously dependent on official policy to support and fund such activities, or on 
individual initiatives by research–orientated clinicians and pathologists (Parkin et al. 2001). As 
a result, European cancer registries differ enormously in the size of the population covered and 
the number of accumulated years of complete data available. Where regional registries do not 
cover the entire national population, they may not be entirely representative of the national 
profile of the cancer burden or patterns of risk. 
Comparable, complete and accurate registry data are essential for drawing reliable 
inferences about geographical and temporal variations in incidence rates. The Cancer Incidence 
in Five Continents series is a major reference work. It was first published in 1962. The ninth 
volume covers new diagnoses of cancer from 1998 to 2002 in 100 registries in 29 European 
countries (Curado et al. 2007). Inclusion in the series is a good marker of the quality of an 
individual registry’s data, because the editorial process includes numerous assessments of data 
quality. 
Cancer mortality measures the impact of cancer, expressed either as the number of deaths 
occurring or as a rate (number of deaths per 100 000 persons per year). Mortality is a product of 
both the incidence and the case fatality of a given cancer. Mortality rates estimate the average 
risk to the population of dying from a specific cancer, while fatality represents the probability 
that an individual with cancer will die from it. Fatality is the inverse of cancer survival – the 
time between the diagnosis of cancer and death. Data are derived from vital registration systems 
in which (usually) a medical practitioner certifies the fact of death and the date and cause of 
death. The International Classification of Diseases provides a standardized system of 
nomenclature and coding, and a suggested format for the death certificate. 
Mortality data are affected by the degree of detail and accuracy of the recorded cause of 
death and by the completeness of death registration. These are known to vary considerably 
between countries and over time. However, the available mortality data are more 
comprehensive than incidence data–the WHO mortality databank contains national cancer 
mortality data for 35 countries in Europe, available over extended periods of time for some 
selected countries. 
In my thesis I also used official statistics from Russian statistical Agency (Goskomstat 
2012) and Kazakh statistical Agency (The Agency of Statistics of the Republic of Kazakhstan 
2012).  
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Tab. 1. List of selected countries, according to available years 
Country Code ICD 8 ICD 9 ICD 10 
The Czech 
Republic 4045 No Yes (1986-1993) Yes (1994-2008) 
France 4080 No Yes (1980-1999) Yes (2000-2008) 
Hungary 4150 No Yes (1980-1995) Yes (1996-2005) 
Italy 4180 No Yes (1980-2002) Yes (2003-2007) 
Kazakhstan 4182 No Yes (1981-2003) Yes (2004-2008) 
Norway 4220 No Yes (1986-1995) Yes (1996-2008) 
The Russian 
Federation 4272 No Yes (1980-1998) Yes (1999-2006) 
Sweden 4290 
Yes 
(1980-1986) Yes (1987-1996) Yes (1997-2008) 
Source: WHO Mortality Database 
5.2 International classification of diseases 
The purpose of the coding process is to select the underlying cause of death and to translate the 
literal text of the listed conditions into ICD codes (WHO 1977, 1992). The selection of the 
underlying cause is very important, since the available international data used for between 
country comparisons are based on this single underlying cause. The ICD international coding 
rules are intended to promote in selecting this underlying cause in difficult cases. 
All countries use the ICD codes to code the cause of death, but usually they apply different 
revisions of the ICD. In the 1990s, there were two revisions that were used in Europe (ICD-9 
and ICD-10) that, in spite of common principles, have important differences – such as the 
number of codes (around 6,000 in ICD-9 and 12,000 in ICD-10). In the mid-1990s, most 
countries still coded using ICD-9; and the dates of any implementation of ICD-10 have varied 
across countries. This simultaneous use of different revisions of the ICD may lead to problems 
of comparability. (Jougla, E. et al. 2011). 
Most countries are now routinely coding causes other than the underlying cause. This 
multiple coding is very useful because it facilitates the assessment of the consistency of the 
certification process and permits comparability studies based on multiple cause analysis. 
However, the total number of coded causes varies (and only a few countries code all the causes 
of death). 
In most countries the selection of the underlying cause of death in the mid-1990s was still 
done manually by trained coders using the ICD rules, but an increasing number of countries 
began to use, or planned to implement, an automated coding system. This development is very 
important for two reasons. It will lead to marked improvement in the inter-country homogeneity 
of coding; and it will facilitate the coding of all the conditions for each death. (Jougla, E. et al. 
2011) 
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Tab. 2 List of leading causes of death according to the revisions of the International Classification of Diseases 
Causes of death 














1. All causes  A000  B00 1000 AAA 










































































7.1.1 MN of prostate 185 A057 185 B124 1040 C61 
7.1.2 MN of larynx 161 A050 161 B100 1033 C32 
7.1.3 MN of lip, oral 




B08 1027 C00-C14 
7.1.4 MN of trachea, 




B101 1034 C33-C34 
7.1.5 MN of colon, 









7.1.6 MN of 
oesophagus 
150 A046 150 B090 1028 C15 
7.1.7 MN of lymphatic 










7.1.8 MN of stomach 151 A047 151 B091 1029 C16 
7.1.9 MN of  female 
breast 
174 A054 174 B113 1036 C50 
Source: WHO Mortality Database documentation and ICD (http://www.who.int/classifications/icd/en/) 
According to the selected countries four different causes of death code description tables 
were used. Table 2 illustrates codes of selected causes of death for all selected countries in taken 
time period 1986-2008. These list of codes for the selected causes of death were taken from the 
basic tabulation list and the special coding for some newly independent states of former USSR 
in the ninth revision. We must mention that according to the code descriptions of cause of death, 
which was presented by WHO, codes in case of Kazakhstan and the Russian Federation for 
calculation of mortality intensities from Basic Tabulation List table 6 of the ICD9 and Mortality 
tabulation List 1 of the ICD10 were used, codes for the other selected countries used ICD8, 
ICD9 and ICD10 detailed third and forth character. 
The selection of cancer sites for this thesis is by no means definitive, a total of 11 specific 
cancer sites were selected for analyzing among males and females, excluding malignant 
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neoplasms (see Table 2). Some of these sites include two or more distinct cancer types with 
different epidemiologies and implications, for example colorectal cancer, which comprises both 
colon and rectal cancers; malignant neoplasm of oesophagus, which comprises both squamous 
cancer of the upper and middle third and adenocarcinoma of the lower third; cancer of lip, oral 
cavity and pharynx; and malignant neoplasm of trachea, bronchus and lung. The ability to 
model different cancer types within a site was limited by the available data. 
Mortality data by main causes of death among the selected countries were collected 
according above mentioned list of codes, taking in account that fact, the mortality data in the 
case of some selected countries is relatively new, for instance, most of selected European 
countries switched to the 10
th
 revision of the ICD in middle of 90s. At the beginning of 2000, 
they were already finished their transition to ICD10. The situation in Kazakhstan was quite 
different. Kazakhstan started its transition to 10
th
 revision of the ICD later than all other selected 
countries, only in 2004. (World Health Statistics 2008) 
Standardised death rates by main causes of death in Kazakhstan proved that the cause-
specific mortality levels for this country in the following years after switching to ICD10 were 
transformed without any large fluctuation in selected rates. Standardised death rates showed the 
number of death from selected causes per 100.000 populations in a given year, which are 
separated for males and females. So we can say that Kazakhstan succeeded in transformation to 
ICD10 in 2004. 
5.3 Adopted approaches and methods used 
In order to capture major trends and patterns of the Republic of Kazakhstan, the Russian 
Federation and some selected European countries (the Czech Republic, France, Hungary, Italy, 
Norway, and Sweden) the following conventional mortality indicators were used: Crude Death 
Rates (CDR), Age–Standardised Death Rates (SDR), and Life expectancies. In addition, one 
more conventional indicator is used, namely the method of decomposition. The analysis of 
mortality is based on abridged, five–year mortality tables. 
The Crude Death Rate (CDR) describes mortality in relation to the total population. 
Expressed per 100,000 inhabitants, it is calculated as the number of deaths recorded in the 




The crude death rate is the ‘crude’, unadjusted mortality per person year, specified as the 
midyear population. Thus, the population structure strongly influences this indicator, as age is a 
major determinant of mortality. All other things being equal, in a relatively ‘old’ population, 
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there will be more deaths than in a ‘young’ one because mortality is higher in higher age 
groups. (Free medical textbook 2011). 
For comparisons, the age effect can be taken into account. The direct method is applied for 
standardisation by using a standard population. The (Age–) Standardised Death Rate (SDR) is a 
weighted average of age-specific death rates. The weighting factor is the age distribution of a 
standard reference population. The standard reference population used is the ‘European standard 
population’ as defined by the World Health Organisation (WHO). Since the European 
Population Standard is a unisex standard, it also can be used for comparison between sexes. 
 
Ps is the total standard population. As most causes of death vary significantly with people’s 
age and gender, the use of standardised death rates improves comparability over time and 
among countries and regions. (Natural vital statistic reports 2009). 
Life expectancies can be calculated for any age. They refer to the mean number of years still 
to be lived by a person who has reached a certain exact age, if subjected throughout the rest of 
his or her life to the actual mortality conditions (age–specific probabilities of dying). Life 
expectancies are calculated using a life table. In order to calculate life expectancy, life tables 
were calculated based on population and mortality data in 5–year age groups up to the age of 
85+ (0;1–4; 5–9;10–14; …; 80–84; 85+). 
The study uses the classical demographic method of decomposition, which is based on 
calculating the contribution of individual age groups to the overall difference between two life 
expectancies at birth (e0). We used the approaches proposed by Pressat (Shkolnikov et al. 
2001). The difference in life expectancies may be expressed exactly as the sum of age–specific 
effects. (Shkolnikov, V. 2001) 
 
where: 2 , 1 ξ ξ l l and 2 , 1 n n l l ξ + ξ + is a table number of persons alive at exact age ξ 
and ξ + n from mortality tables of population 1 and 2. 2 1 ξ , ξ e e and 2 , 1 n n e e ξ + ξ + is a 
expectation of life at exact age ξ and ξ + n from mortality tables of population 1 and 2. For 
analysis of differences in life expectancies, we used Pollard’s (1988) two–dimension method: 
 
where: 1 , 1 I x x n m + and ,2 1 I x x n m + is a mortality rates by causes of death of 
population 1 and 2 in age groups x and x+n. xs w is a weight of average future years lived 
beyond age x that tells how much influenced the mortality rate deferential, 
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where: 2 , 1 ξ ξ l l and 2 , 1 n n l l ξ + ξ + is a table number of persons alive at exact age ξ 
and ξ + n from mortality tables of population 1 and 2. 2 1 ξ , ξ e e and 2 , 1 n n e e ξ + ξ + is a 
expectation of life at exact age ξ and ξ + n from mortality tables of population 1 and 2. For 
calculation of the weights of exact age 0, used the following formula: 
 
The sum of individual contributions by age groups and causes of death is exactly equal to 
the difference between the values of life expectancies at birth of the two populations, because of 
the interactions of individual causes of death. (Global health risks 2009) 
The decompositions are made for each country separately as well between Kazakhstan and 
selected European countries during the twenty–year period under consideration, and separately 
by sex so that comparisons may be made in the age and sex patterns of contributions to over 
time.  
Decomposition of life expectancy at birth has the advantage of weighing age groups so that 
young age groups have a higher impact on the remaining life expectancy than older ones. It is 
important for Kazakhstan where infant mortality is very high. Correspondingly, it has a great 
influence on life expectancy also. Negative and positive contributions of all age groups sum up 
the total difference observed in life expectancy. Decomposition is based on life tables up to the 
age 85+. Unspecified deaths numbers were proportionally distributed. 
In this thesis I also use so called Potential years of life lost (YPLL). According to the 
Association of Public Health Epidemiologistd in Ontario it is a summary which obtains 
measuring of premature mortality. This measuring includes explicit way of weighting deaths, 
which were occurred at younger ages (Association of Pubic Helath Epidemiologists in Ontario, 
2005). 
41 
Askhat Ashimov: Trends and patterns of cancer mortality in Kazakhstan in comparison with 
some selected European countries from 1986 to 2008 
Chapter 6 
Analysis of general mortality trends in the selected 
countries between the period of 1986-2008  
6.1 Changes in life expectancy at birth among the selected 
countries 
Fig. 6. Development of life expectancy at birth, Czech Republic 
 
Sources: Author’s own calculations based on data from WHO mortality database     
On this figure 6 we make development of life expectansy at Czech Republic from 1986 till 
2008, for both sex and and derive a curve of the difference in life expectancy between men and 
women. How we can see that life expectancy of females in the Czech Republic is longer than  
males. According to statistics, male life expectancy in the Czech Republic is 74.1 years and 
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women - to 76.5 years, but now they can count to 75 and 80 years respectively. The difference 
in life expectancy between men and women differ in 6.4 years. Figure 6 shows that difference 
progressively decreases, and in 2008 it was 6,5 years.  
Life expectancy in the Czech Republic continues to grow from year to year. Only in the last 
20 years, male life expectancy increased by seven years, and women for 5 years. 
The Czech Republic belongs to the EU countries, where life expectancy is increasing at a 
record pace. Over the past 100 years, life expectancy increased by about 25 years. 
Fig. 7. Development of life expectancy at birth, France 
 
Sources: Author’s own calculations based on data from WHO mortality database 
On that figure 7 we can see life expectancy at birth in France at period 1986-2008 years. 
The average life expectancy of French women in 1986 was 80 years, and French man 71.7 
years. But the total average life expectancy of French women - 83.8 years for men - 76.7 years, 
i.e. on average - 80.2 years (Japanese live on average 81.9 years, and the inhabitants of Monaco 
- 81.2 years).  
It should be noted that the population of France could actually be proud of one of the 
highest levels of life on the planet according to the classification of the UN. In terms of human 
development index, which is calculated on the basis of life expectancy, education levels and 
living standards, France is in 12th place. 
These results have been achieved, primarily due to one of the best in the world of social 
insurance and health care. Thus, the French social security system includes unemployment 
benefits, old age pensions and disability, different family allowances, reimbursement of 
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Fig. 8. Development of life expectancy at birth, Hungary 
 
Sources: Author’s own calculations based on data from WHO mortality database 
We can see from the figure 8 above, life expectancy of Hungary is not so high. Estimated 
life expectancy at birth: the entire population - 72.4 years, female – 77.1 years male - 68.7 years 
old (as of 2005). Difference in life expectancy is 8.4 years. As we see the curves are not so 
fluctuating, but have a positive tendention, except the ningthteenth years of the 20
th
 century, 
when the flow of the curves was in the negative direction. The second particularity is that the 
difference between life expectancy of male and female decreases, which can be also explained 
by economic, political and social stability in the country. 
Hungary is one of the EU state which became memner states at same time with the Czech 
republic. There were no wars or military periods during the recent years; the conditions of work 
and holidays for men and women has been very unified for both sex. Probably this is also the 
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Fig. 9. Development of life expectancy at birth, Italy 
Sources: Author’s own calculations based on data from WHO mortality database 
Italian Institute of Statistics says that in Italy the highest life expectancy in the world. The 
average life expectancy of Italian men, according to a study of 77.2 years and women - 82.8. 
Life expectancy for males in 1974 to 2003 increased by 7 years, and women - nearly 8. Do not 
forget that Italy is one of the countries of Europe, where people smoke more in comparison to 
other countries.  
But Italians are among the most healthy people with the highest life expectancy. We claim 
that this is due to red wine, olive oil and Mediterranean food. These parameters can be linked to 
the fact that Italian doctors and medical personnel are among the most highly qualified in the 
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Fig. 10. Development of life expectancy at birth, Kazakhstan 
 
Sources: Author’s own calculations based on data from WHO mortality database 
In 2009 the life expectancy of the population in the country was 68.6 years. If we talk about 
the year 2008, it was 67.1 years, that is, there is an increase in life expectancy. However, I 
would like to say that men have a life expectancy increased by 1.7 years and for women - 1.1 
years. However, as noted on the graph in Kazakhstan is the difference in the gap in life 
expectancy between men and women over the natural difference in 5 years and 9.9 years. 
Sexual imbalance has developed because of the high mortality of men compared to women 
Men must have a high mortality associated with social causes. It is dominated by causes 
such as suicide, injuries, deaths due to smoking, alcohol use, stroke, heart attacks, nervous 
disorders, it is a depression.  
In this country on average, men die before retirement (under the legislation Kazakh men 
retire at 63 years), because life expectancy is only 62.8 these years, women - 73.6 years. In rural 
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Fig. 11. Development of life expectancy at birth, Norway  
Sources: Author’s own calculations based on data from WHO mortality database 
The rankings of countries on this indicator as a standard of living into account the following 
factors: life expectancy, educational attainment and the value of GDP per capita (at purchasing 
power parity). The standard of living in Norway is among the highest in the world. You can see 
from our figure that life expectansy is so high. Average age of women reaches 83 years, and for 
male 79 years. Norway shares the 13th place with New Zealand. It would seem, is not very 
high. However, the average life expectancy - 80.2 years (males - 77.8, female - 82.5). In the 
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Fig. 12. Development of life expectancy at birth, Russia 
 
Sources: Author’s own calculations based on data from WHO mortality database 
Currently, life expectancy for Russian men is the lowest in Europe. The average Russian 
citizen males lived 58.8 years. The Russian women, life expectancy, according to Rosstat data, 
is 72 years. 
For male life expectancy Russia is 134th in the world, and women - the 100-th place. The 
average life expectancy of Russians as a whole - just over 65 years. "The positive trend of 
mortality reduction, outlined in the 1995-99 years, unfortunately, has not been fixed," - said 
Minister of Health and Social Development Minister Mikhail Zurabov 
The main factors for high mortality of Russians - cardiovascular diseases and external 
causes (accidents, poisonings and injuries).  
A distinctive feature of the demographic situation in Russia - a vast difference between life 
expectancies of men and women. In the developed countries and countries with developed 
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Fig. 13. Development of life expectancy at birth, Sweden 
 
Sources: Author’s own calculations based on data from WHO mortality database 
According to the data, life expectancy in this country is growing and is currently 83.2 years 
for women and for men - 79.1. Sweden is one of the countries where ife expectancy is relatively 
high. Scandinavian states are particular by their social conditions and way the Government of 
the countries treat its inhabitants – there is a well developed social infrastructure, including 
ecological layouts. Scandinavian countries take care not only about individuals and human 
beings, but also nature, flora and fauna, as well as of other natural surroundings. That is the 
most probable reason why people live in consensus with nature, enjoy their lives and live until 
that high age. 
After comparing countries I would like to represent the figure 11, 12 which is showing the 
comparison of life expectancy for males only in the mentioned countries. The “winners” in the 
categoria are France and Sweden (the reasons have been described in the text above). The worst 
results among the smparable states are in the Norway, Russian Federation and Hungary.
1
  
This difference represents the average around 3-4 years. The highest life expectancy shows 
France, in contrast to Kazakhstan, which in the period from 1995-2000 shows the worst results 
in life expectancy after 65 years. Also very rapid changes can be observed in countries: Czech 
Republic and Hungary, from 1992 year on those countries are observed a significant increase in 
life expectancy, which grew at an average of about 2-3 years.  
With regards to the countries: Kazakhstan and Russia, here, in 1991, one can observe a 
sharp recession life expectancy of the male population, we can suggested that this is due to with 
the collapse of the Soviet Union and formation the independence of these countries.  
                                                     
1
 Also I would like to mention “the worst”results are just within this particular group of countries, but 
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6.2 Decomposition of life expectancy at birth 
The following figure 14 shows ratio of mortality rate of Czech Republic and Sweden at 2006 
year. According to graph the peak of mortality of man on those countries is on ages 60-64, the 
most prevalent factors are neoplasm and circulatory disease. 
Fig. 14. Decomposition of the Czech Republic-Sweden gap in life expectancy by age and main causes of death for 
males, 2006 
 
Source: Author’s own calculations based on data from WHO mortality database 
Next figure 15 shows the mortality rate of male population of Kazakhstan and Sweden at 
2006 year. In the ratio of these two countries we can say that the largest number of deaths 
occurring in the age group 55-59 years. The most common diseases are neoplasm, circulatory 
and digestive. 
Fig. 15. Decomposition of Kazakhstan-Sweden gap in life expectancy by age and main causes of death for males, 
2006 
 
Source: Author’s own calculations based on data from WHO mortality database 
Given figure 16 shows the ratio of mortality of the female population on Czech Republic 
and France at 2006 year. Based on the graph we can say that female population reached 85 
years of age die mostly from circulatory diseases. A big percentage of death is from neoplasm 
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years. The maximum of the chat is shown in the point 55, 59 years old – the year of retirement 
in many of the countries.  
Fig. 16. Decomposition of the Czech Republic-France gap in life expectancy by age and main causes of death for 
females, 2006 
 
Source: Author’s own calculations based on data from WHO mortality database 
The next figure 17 shows the mortality rate of female population in Kazakhstan and France 
at 2006 year. The graph indicates that the female population from 25 till 79 very often dies from 
circulatory disease and digestive diseases. Female population has attained 85 years of age 
mostly are subject to circulatory diseases. There is also percentage of people that die from 
neoplasm desease between year 55, 59 and 80, 84. The female curve of decomposition of the 
main causes of death in the Czech Republic and France is quite different from the figure 17, as 
female curve shows the growth of deseases in the late ages. While making decomposition of 
Kazakhstan – France female’s life expectancy and causes of death we can say that the main 
percentages of deaths were causes by circulatory deseases, primarily at the ages 35+. I have not 
mentioned yet that there is one more very obvious death cause – external factors which obtain 
relatively high percentage in all decompositions.  
Fig. 17. Decomposition of Kazakhstan-France gap in life expectancy by age and main causes of death for 
females, 2006 
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Chapter 7 
Analysis of mortality trends by main causes of death in 
the selected countries between the period of 1986-2008  
Followed graphs which decrees more common causes of mortality in listed above countries. The 
most common causes of death as for male and for female population are circulatory and 
neoplasm diseases. Next factors occurring more often on those countries are others, external. 
And should be noted that in Russia, Kazakhstan, France and Norway more often death due to 
cause of infectious diseases. 
Fig. 18. Age-standardised mortality rates by main causes of death of mortality levels in the selected countries for 
males, 2006 
 
Source: Author’s own calculations based on data from WHO mortality database 
On the figure 18 I represent proportion of male death causes according to the states. Thus 
we can see that the most frequents causes of death are circulatory diseases – very likely for 
Kazakhstan, the Russian Federation and Hungary, but less likely for France, Italy and Norway. 
The second “most deadly disease" is neoplasm disease, which is characteristic for all the states 
independent on social infrastructure, development or progress. Kazakhstan and the Russian 
Federation have a big percentage of other death causes, such as car crashes, fires, natural 
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Fig. 19. Age-standardised mortality rates by main causes of death of mortality levels in the selected countries for 
females, 2006 
 
Source: Author’s own calculations based on data from WHO mortality database 
On the figure 19 I represent proportion of female death causes according to the states. The 
circulatory diseases are on the first position as in all previous decompositions. The same thing I 
can say about neoplasm diseases, as they are common for all the compared states, moreover the 
percentage is particularly the same. I would also like to mention about infections, as it can be 
called the disease of the previous century, but not very common for nowadays. The fiure shows 
that a small percentage of infection diseases is still in Kazakhstan, Norway, France and the 
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Fig. 20. Age-standardised mortality rates by all causes of death in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Fig. 21. Age-standardised mortality rates by all causes of death in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
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Fig. 22. Age-standardised mortality rates by cause of death from infectious diseases in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Following figure 23 shows the mortality rate of female from infection diseases on period 
from 1986 to 2008 years. How in previous graph the highest rate of mortality shows Kazakhstan 
and deferens of dead between male and female is around 600 – 650 thousands of people. 
 
Fig. 23. Age-standardised mortality rates by cause of death from infectious diseases in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
That figure 24 shows mortality rate of male population case of neoplasm diseases on 1986-
2008 years. The highest mortality rate from cancers noted in Hungary, however the lowest rate 
noted in Sweden. The positive trend shows all of the above mentioned countries. On the base of 
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Fig. 24. Age-standardised mortality rates by cause of death from neoplasm diseases in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
On that figure 25 shows the mortality rate of female population from neoplasm diseases 
from 1986 till 2008 years. The highest point of death is in Norway and the lowest rate of 
mortality in France.  
Fig. 25. Age-standardised mortality rates by cause of death from neoplasm diseases in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
The next figure 26 shows the rate of mortality from circulatory diseases from 1986 till 2008 
years. In case of circulatory diseases the highest rate of mortality was in Russia and Kazakhstan. 
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Fig. 26. Age-standardised mortality rates by cause of death from circulatory diseases in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Figure 27 shows the mortality rate of female population from circulatory diseases from 1986 
till 2008 years. These data are almost identical to the dates of male mortality. The only 
difference is clearly seen is number of deaths in different countries it is approximately 100 to 
350 thousand. Men die more than women. 
Fig. 27. Age-standardised mortality rates by cause of death from circulatory diseases in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Next two figures 28, 29 shows disease associated with respiratory of male and female in 
period from 1986 to 2008. The highest rate of dying in case of respiratory diseases is noted in 
Kazakhstan on 1995 year, registered a record number of deaths, which are around 220 per 100 
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Fig. 28. Age-standardised mortality rates by cause of death from respiratory diseases in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Fig. 29. Age-standardised mortality rates by cause of death from respiratory diseases in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Those figures 30, 31 show the mortality rate of digestive diseases at male and female 
population at mentioned countries. The highest rate registered in Hungary, followed by the 
countries: Kazakhstan and Russia. We can assume that in Hungary and Russia population abuse 
the alcohol and due to that we can see such kind of rate. But in Kazakhstan can be assumed the 
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Fig. 30. Age-standardised mortality rates by cause of death from digestive diseases in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Fig. 31. Age-standardised mortality rates by cause of death from digestive diseases in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Following two figures 32, 33 show on the rate of mortality on female and male population 
from the external disease on period 1986-2008 years. In Russia and Kazakhstan we can see the 
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Fig. 32. Age-standardised mortality rates by cause of death from external diseases in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Fig. 33. Age-standardised mortality rates by cause of death from external diseases in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
The highest point was matched in 1994 year. Probably this is due to rampant crime on that 
period. But I would like to note that on last years this trend markedly reduced. Most positive 
trend is showing countries Italy and Sweden. 
On that figures 34, 35 we can see the average mortality rate of men and women from 
residual factors on period of 1986-2008 years. The most rate of mortality we can see on 
countries of Russia, Kazakhstan, France, and the lowest rate was surveyed in Czech Republic 
and Hungary. According to that graph we can say that residual factors have the same effect to 
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Fig. 34. Age-standardised mortality rates by cause of death from others (residual) diseases in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Fig. 35. Age-standardised mortality rates by cause of death from others (residual) diseases in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
That following figures 36, 37 show percentage of deaths from various common diseases of 
the male and female population the above mentioned countries in 2006 year. Overall trends 
indicate that the person male from birth till 14 years old more susceptible to death related to the 
other factors, external and neoplasm. Further mean the general trend shows that the male 
populations from 15 to 44 years are particularly susceptible external facts of deaths and 
circulation cases. Male population of 4 -9 years are subject to neoplasm diseases. The rate of 
mortality to female population from birth till 14 years old, shows that the more popular cause of 
death is others, external and neoplasm diseases. After from 15 till 44 those cases are external, 
circulatory and neoplasm diseases. Female population after 44 years old are often subject to 
illnesses based on circulatory and neoplasm diseases. More common causes of death both for 
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Infectious Neoplasm Circulatory Respiratory Digestive External Others
Italy
Fig. 36. Number of deaths by main causes of death of mortality structure in the selected countries for males, 
2006 
Source: Author’s own calculations based on data from WHO mortality database 
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Infectious Neoplasm Circulatory Respiratory Digestive External Others
Sweden
Fig.37. Number of deaths by main causes of death of mortality structure in the selected countries for females, 
2006 
  
Source: Author’s own calculations based on data from WHO mortality databas 
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Chapter 8 
Analysis of mortality trends by major cancer sites in the 
selected countries between the period of 1986-2008  
In this chapter I would like to make a review of a lot of information about cancer’s trends, about 
the mortality as a reason of cancer disease, about the development of cancer and methods to 
stop and control it in nowadays.  
In this section, I compare the reasons for deaths from cancer of the reasons for deaths from 
other diseases in the Republic of Kazakhstan: infectious diseases, internal and digestive 
diseases, circulatory system. The thesis presents the change in the number of deaths by cancer 
of the disease in different age categories during the period from 1981 to 2008. Besides, 
presented in more detail in the study selected the most common types of cancer. 
 
Malignant neoplasm of trachea, bronchus and lung 
The most popular disease in the world among people is a disease like cancer. Each year, the 
number of cancer patients is growing. For example, such an increase can be traced: in women 
each year become ill at an average 330.000 and 900.000 men. This statistic confirms that the 
basis of increased mortality is a disease like cancer. 
In worldwide there are 45 % of cases of cancer. In the Northern Europe there are about 70 
%. More of all cases are caused by cigarette smoking, including environmental tobacco smoke. 
For example, 80 % of people with disease as cancer have especially lung cancer. To incidence 
air pollution and some occupational exposures make a minor contribution. There is no effective 
treatment in this case. Doctors in case of lung cancer gave as prognoses that less than 15 % of 
patients have the five–year survival rate. 
These tumours arising from epithelia of lungs or bronchi, or the trachea, and this type of 
cancer always exclusively involves carcinomas. 
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Nowadays lung cancer is the most common and malignant sickness in the world. It is one of 
the most main reasons of death from cancer, particularly amongst men. The development of 
cancer especially of lung cancer has increased rapidly and it now according to statistics 
accounts for an estimated 901,746 new cases each year among men and 337,115 among women. 
In the EU the highest rate of cancer death in males has the cancer of the trachea, bronchus 
and lung (lung cancer). And females have this type in the third highest rate. Overall, the 
mortality rate for lung cancer was around five times higher in males than in females. It is about 
50.3 per 100,000 among men and 10.3 per 100,000 among women. The national mortality rate 
in all countries is higher in males than in females.  There were considerable variabilities in the 
rates between countries among males.  
These difference we are able to find and understand if we go through the smoking history. 
The highest rates are in the former socialist economies of Europe: the Czech Republic and 
Hungary. Methods about lung cancer rates represent high and low levels. One is for tobacco 
smoking and another is for control of tobacco use.  
As shown in the chart, Kazakhstan is situated in diameter and does not deviate much from 
other countries. Positively, the number of diseases in Kazakhstan decreases. 
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Fig. 38. Age-standardised mortality rates by malignant neoplasm of trachea, bronchus and lung in 1986-2008, 
males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Fig. 39. Age-standardised mortality rates by malignant neoplasm of trachea, bronchus and lung in 1986-2008, 
females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Malignant neoplasm of colon, rectum and anus 
In developing countries such type of cancer as cancers of the colon and rectum is rare. But in 
the affluent societies this type of cancer is the second among the most frequent malignancy. 
According to statistics, there are more than 940.000 cases per year of new cases with such type 
of cancer worldwide.  One of the most important factors, which make the development of 
cancer, is lifestyle involving a diet rich in fat, which is combined with low physical activity and 
refined animal protein and carbohydrates. If you want to decrease risk of cancer’s development, 
you should increase fruits and vegetable consumption and decrease meat consumption. The 
earliest studies because of sequential genetic alterations mediate development of colon cancer 
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clustering. Familial adenomatosis polyposis and hereditary non–polyposis colon cancer are the 
typical syndromes. For early detection colonoscopy is the most reliable means. Progressively 
improved treatment has resulted in a five-year survival rate of about 50 %. The majority of 
cancers are adenocarcinomas. It is including the colon and rectum, and accounts for more than 
90 % of all large bowel tumours (World Health Organisation 2003). 
Regarding to neoplasm of colon, rectum and anus, so here it is necessary to say that 
Kazakhstan is doing far better than other countries. 
Fig. 40. Age-standardised mortality rates by malignant neoplasm of colon, rectum and anus in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
 
Fig. 41. Age-standardised mortality rates by malignant neoplasm of colon, rectum and anus in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
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Malignant neoplasm of stomach 
In Kazakhstan the second of the most common cancers globally is the stomach cancer. It is also 
the second among males and the fourth most common among females. Stomach cancer in the 
southern Kazakhstan and in the western Kazakhstan has the highest incidence rates in 
comparison with all other types of cancer. Average ratio between cases among men and women 
is about 1.9: 1. In 2008, there were 2.726 newly diagnosed cases of stomach cancer. 
In the world the cancer of the stomach is the most common among all cancer’s diseases. It is 
calculated that usually per year new people with this disease are 870.000 new cases. On the first 
place in mortality from cancer is mortality because of lung cancer and on the second place is 
mortality because of stomach cancer.  Incidence is declining worldwide. In most European 
countries during the past 50 years this tendency has fallen by more than 60 %. It is because of 
markedly decreased consumption of salt- reserved food. Also this trend is mainly due to, 
increasing avoidance of a high-salt diet and availability of fresh vegetables and fruits. This type 
of consumption must be during the whole year. For example, chronic atrophic gastritis are 
caused because of infection with Helicobacter pylori. This factor is considered in the 
development of stomach cancer.  Doctors calculated that usually less than 30 % of patients with 
such disease have five–year survival rates and even less. 
Strangely enough, I found that Kazakhstan is the one of the first places in MALIGNANT 
neoplasm of stomach. The worse thing is just the Russian Federation. Due to the relative 
proximity of the two countries it can be assessed that the main reason of cancer is diet (World 
Health Organisation 2003). 
Fig. 42. Age-standardised mortality rates by malignant neoplasm of stomach in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
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Fig. 43. Age-standardised mortality rates by malignant neoplasm of stomach in 1986-2008, females 
 Notes: Missing data 
for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
 
Malignant neoplasm of prostate 
In developed countries mainly among older men the mortality because of prostate cancer 
accounts for about 200.000 cases annually in the world. This is because of low physical activity 
and such risk factor as caloric intake.  The lower risk have the Asian men, white men have an 
intermediate risk, and the highest risk have black men have. Recorded incidence is increasing in 
many countries, partly as a result of screening for elevated serum levels of prostate-specific 
antigen.  
Testicular cancer mainly affects young men, with close to 50.000 new cases each year 
worldwide. This tendency is increasing in many developed countries, but it is difficult to find 
the solution, because its etiology is mostly unknown. Doctors calculated that patients with this 
disease are able to leave longer than people with other types of cancer. So, the five-year survival 
rate is higher than 95 %. But people must use cisplatin and have chemotherapy. There are a lot 
of cases, where it is possible to stop the developing of cancer and to be healthy, but all this is 
after long procedures with chemotherapy. 
Kazakhstan has the lowest rate among selected countries. In this type of graph can be said 
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Fig. 44. Age-standardised mortality rates by malignant neoplasm of prostate in 1986-2008 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Malignant neoplasm of female breast 
Breast cancer is the most common result of mortality than other types of cancers. In the 
world there is no country with a really low level of such type of cancer. It is calculated that the 
rate of people with such disease as breast cancer in the EU was 20.6 per 100.000. According to 
statistics, breast cancer is situated one the fifth place of all cancer mortalities. 
There are more than one million new cases of breast cancer in the world per year, and it is 
the most common affecting women malignancy. It is the greatest risk for affluent societies. It is 
about incidence rates of 80 per 100.000 population per year. All this is happened because of a 
lot of etiological factors. The worldwide cancer epidemic has its own reproductive history, for 
example early menarche, late or no pregnancy at all. But not only this affects women. Also 
Western lifestyle is very unhealthy. Now I am talking about lack of physical activity and high 
caloric diet.  
Now the mortality rates of breast cancer started to decline in such countries as Western 
Europe, North America and Australia. But this is not because of right diet full of fruits and 
vegetables, but because of improvements in early detection, for example tamoxifen and 
chemotherapy.  
According to doctors, 70% of people with this disease are able to live and reach five–year 
survival rates in most developed countries. Because of new technologies and development in 
science it is possible to recognize the breast cancer absolutely in the beginning and that is why 
to decrease the mortality to 30%. Of course all this is because of screening trials of 
mammography, but it is limited, because this evidence could be just in population–based 
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In a taken time period Kazakhstan had low rates, but now in Kazakhstan as in the Czech 
Republic rates of breast cancer mortality are extremely growing (World Health Organisation 
2003). 
Fig. 45. Age-standardised mortality rates by malignant neoplasm of female breast in 1986-2008 
 
Notes: Missing data for Italy 2004-2005, 2008;  Missing data for Kazakhstan 1992; Data for the Russian Federation 
is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
 
Malignant neoplasm of lymphatic and haemopoietic tissue 
Hodgkin disease is diagnosed as malignant lymphomas. Sometimes it could be non-Hodgkin 
lymphoma. In developing countries mainly Hodgkin disease is able to afflict children and the 
elderly, but in developed countries it is able to afflict young adults. There are diagnosed more 
than 62,000 of new cases per year. This disease is spreading and developing in the whole world 
nowadays. Mostly in developed countries are diagnosed more than 280,000 new cases every 
year.   
In some areas in Africa where there is malaria, was found Burkitt lymphoma as a subtype of 
malignant B–cell lymphoma. Now it is common in Africa. Also B-cell lymphomas may be 
caused by immunosuppressant. These two lymphomas are associated with the Epstein–Barr 
virus. People with this Hodgkin disease have a chance of 70 % to reach a five–year survival rate 
and for non–Hodgkin lymphomas has increased to 60–70 %. 
A heterogeneous group of neoplasms of lymphoid tissue is covered with the term 
lymphoma. Traditionally, lymphomas are categorized as Hodgkin disease and non–Hodgkin 
lymphoma. Differences of it are in the behaviour and response to treatment. There is a range of 
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Fig. 46. Age-standardised mortality rates by malignant neoplasm of lymphatic and haemopoietic tissue in 1986-
2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008;  Missing data for Kazakhstan 1992; Data for the Russian Federation 
is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
 
Fig. 47. Age-standardised mortality rates by malignant neoplasm of lymphatic and haemopoietic tissue in 1986-
2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008;  Missing data for Kazakhstan 1992; Data for the Russian Federation 
is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Malignant neoplasm of lip, oral cavity and pharynx 
Oral cancer is such type of cancer that encompasses cancers arising at all sites within the oral 
cavity and pharynx. This may obscure important variations in both the mortality and the effect 
of aetiological factors for the different cancer sites. 
In the EU the mortality rates for above mentioned cancers were about 4% of the rate for all 
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In 2000, the highest rates in men were in Hungary (29.47). Also I would like to add some 
more statistics about men rates in different countries: France (13.1), Russia (12.72). Kazakhstan 
(9.52) and the Czech Republic (9.43) are approximately on the same level. The lowest rates 
were found in Norway (3.85) and Sweden (3.0). 
In Hungary in 2000 this rate in female was 4.32. It was relatively little variation in 
comparison with the other countries. The ratio between the male and female rates in each 
country varied widely, from around 2:1, for example Norway and Sweden. This rate in 
Hungary, France and Russia is up to more than 7:1. 
Fig. 48. Age-standardised mortality rates by malignant neoplasm of lip, oral cavity and pharynx in 1986-2008, 
males 
 
Notes: Missing data for Italy 2004-2005, 2008;  Missing data for Kazakhstan 1992; Data for the Russian Federation 
is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
 
Fig. 49. Age-standardised mortality rates by malignant neoplasm of lip, oral cavity and pharynx in 1986-2008, 
females 
 
Notes: Missing data for Italy 2004-2005, 2008;  Missing data for Kazakhstan 1992; Data for the Russian Federation 
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Source: Author’s own calculations based on data from WHO mortality database 
Malignant neoplasm of larynx 
There is an organ in the neck of humans, which is called the voice box or the larynx or plural 
larynges. Also reptiles (incl. birds), amphibians and mammals have it in the neck. It is involved 
in sound production, breathing, and protecting the trachea against food aspiration. These vocal 
folds are situated in such place - below where the tract of the pharynx splits into the trachea and 
the esophagus. 
Person has a high chance to be healthy or to leave long life if this disease was recognized at 
an early stage. This rate of mortality because of this type of cancer is little bit over 2 % of the 
rate for all cancers in males, but less than 0.5 % in females. 
Fig. 50. Age-standardised mortality rates by malignant neoplasm of larynx in 1986-2008, males 
 
Source: Author’s own calculations based on data from WHO mortality database 
Cancer of the larynx in males (3.9 per 100.000) was much commoner overall than in 
females (0.3 per 100.000). The national mortality rate was higher in males than in females in all 
countries in the world.  There were consistently very low national rates in females. But there 
was considerable variability in the rates between countries in males. Throughout Europe such 
differences may contribute partially to the variation in mortality from this cancer. According to 
statistics, in EU the mortality rate because of the larynx cancer is 15 times higher in males than 
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Fig. 51. Age-standardised mortality rates by malignant neoplasm of larynx in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008;  Missing data for Kazakhstan 1992; Data for the Russian Federation 
is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Malignant neoplasm of oesophagus 
This type of cancer is the sixth in the world among all other types of cancer. Cancer of the 
oesophagus has more than 400,000 cases per year. The highest rates are in South Central Asia 
and Western Asia. This type of cancer is the most common in developing countries. Squamous 
cell carcinoma is associated with tobacco smoking, alcohol consumption and very hot beverages 
and malnutrition. It was occurred in white men from highly developed countries. 
Adenocarcinoma is the one the most important etiological factors being obesity and chronic 
gastrooesophageal reflux.  But it is very difficult to diagnose this cancer, and that is why the 
most cancers of the oesophagus are detected at an advanced stage. Chances to reach a five–year 
survival rates are less than 15 %. 
In comparison to countries of the Commonwealth of Independent States (CIS) Kazakhstan is 
the country with the highest rates of oesophageal cancer. If we calculate all cancer cases we will 
find that the incidence of oesophageal cancer is 5.1 % of cases among men and 4.1% of cases 
among women. 
This graph surprised me quite - Kazakhstan is on the first place. The reason is that 
Kazakhstan with other countries of Central Asia is falling into the risk region, residents who 
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Fig. 52. Age-standardised mortality rates by malignant neoplasm of oesophagus in 1986-2008, males 
 
Notes: Missing data for Italy 2004-2005, 2008;  Missing data for Kazakhstan 1992; Data for the Russian Federation 
is available until 2006  
Source: Author’s own calculations based on data from WHO mortality database 
Fig. 53. Age-standardised mortality rates by malignant neoplasm of oesophagus in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008;  Missing data for Kazakhstan 1992; Data for the Russian Federation 
is available until 2006  
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To have information about rates, patterns, development and features of other neoplasms or 
sickness is very important. Any information may play a great role in the process of treatment. 
Also it is needed to compare results between different countries and regions, because such 
elements and hormones that make spreading and development of cancer may represent high 
proportions of the rates for all combined cancers. Also it is important to understand that the 
rates for some types of cancer may be lower than they really are according to tests and 
researches. 
Fig. 54. Age-standardised mortality rates by other neoplasms in 1986-2008, males 
 
Source: Author’s own calculations based on data from WHO mortality database 
 
Fig. 55. Age-standardised mortality rates by other neoplasms in 1986-2008, females 
 
Notes: Missing data for Italy 2004-2005, 2008; Data for the Russian Federation is available until 2006  
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Chapter 9 
Causes of cancer and policies for prevention  
In this charter I would like to make a resume of the main reasons of appearance such desease as 
cancer and try to undersstand what to do to stop its spreading in the Word. I would like to 
concentrate my research on that factors or determinants of this sickness, which are able to be 
controlled in case to stop the development of cancer. It is very important to understand clearly, 
what factors or determinants of this sickness have such features as ability to be changed or even 
modified because of environment, people’s activities, habbits, way of life. 
In my current thesis step by step I will determine these factors, which cause on cancer’s 
appearance, developing and spreading, and also according to the European Code Against 
Cancer I will take into account the method, how to prevent cancer. And of course I will stress 
the importance of regular control as a basement of struggle with cancer. 
9.1 Key lifestyle risk factors for cancer  
Tobacco smoking 
One of the most important and understandable reasons of cancer’s appearance as a desease is 
tobacco smoking. According to data, made by experts and scientists all over the Word, in one 
cigarette there are more than 4000 elements, and 40 elements from them have carcinogenic 
features, for example, akrylonitrile,  4 – aminobiphenyl,  2 – naphthylamine, benzene, cadmium, 
benzoapyrene, and chromium (IARC - 1986, IARC - 2004, Hecht - 2005).  
It is reported everywhere and it is not a joke, that in the countries with developed economy 
and science there are around 30% of all 100% cancer cases, which are related exactly to tobacco 
smoking. If we combine countries with developed and developing economies we will be able to 
face in with the other result with amount of 16%.  
Tobacco smoking we are able to understand not only as a great risk for exactly smokers or 
active smokers, but also for passive smokers, who unfortunately may breath this smoke. The 
first and the main method how to stop the prevention of cancer and to decrease the index of 
premature death is to stop smoking (Boyle et al. 2004).  
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According to researches, which were held in Japan, North America and Europe from 87% to 
91% among men and from 57% to 86% among women of lung cancer diseases are associated 
with cigarette smoking. To continue with statistics I need to stress that from 43% to 60% among 
humans of cancer diseases are associated with the influence of tobacco, either in combination 
with alcohol or without it. 
These cancers arise in the oral cavity, larynx, and in the cavity of the esophagus. Finally, the 
meaning share of cancers of the pancreas and the urine bladder, a smaller proportion of the 
stomach cancer, nose and cervix cancers, kidney cancer, and myeloid leukemia, are also 
reasonably associated with tobacco smoking (Boyle et al., 2003).  
The duration of the latent period means that these cancer’s diseases related to tobacco-
smoking, which we are able to notice in current days, are associated with tobacco-smoking 
model in the previous few decades.  
The augmentation of the risk of cancer risk is sharply reduced or even stopped, because of 
reduction of smoking or even quitting. The bonus of tobacco smoking is clear after five years 
and it is more apparent and understandable over time (Godtfredsen and Pisinger, 2007).  
The distribution and quantity of the effect of tobacco smoking in Europe, is particularly 
anxiety (Costanza et al. 2006). The one of the largest manufacturers and major exporters of 
cigarettes in the world is the European Union. The highest results of indexes of tobacco 
smoking and dependence on it are in the Eastern Europe and in the Central Europe (Boyle et al., 
2004).  
By the way according to the data and to the report from 2007 about to control the usage of 
tobacco in Europe we are able to say that rates of smokers between men and women are totally 
different. Men are 40% and women are 18%. And unfortunately now situation is changing not 
to good, but even to the worth. The rate of men-smokers is decreasing, but the rate of women-
smokers is in a contrary increasing, for example, in the Eastern Europe. Now it is a tragedy, 
because those cancer risk-factors are very dangerous for women (Costanza et al. 2006; Mucha et 
al. 2006).  
A huge concern is the fact that in many parts of Europe, the prevalence of smoking remains 
high among general practitioners. On the contrary a way of life of doctors should be exemplary 
in terms of health, rather than destructive. Therefore, such a negative figure should be a target 
for immediate action. 
The number of deaths from cancer of the lung, bronchus and trachea can be used as an 
indicator of the number of smokers who die prematurely. And also as a marker of past trends in 
population exposure to tobacco smoke. These figures show a clear difference in cancer risk 
between men and women. Age-standardized mortality rate in 2007 was 65 per 100.000 
population among men and 13.8 per 100.000 among women (WHO 2004). Trend analysis 
provides a fairly optimistic outlook. 
Since the early 1990s there was a decrease in mortality from cancers associated with 
tobacco-smoking among the male population. Thanks to the anti-tobacco campaigns, which are 
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held in many European countries, has become markedly apparent decrease in smoking 
prevalence among men since the early 1980s. This figure reflects the growing prevalence of 
smoking among female population since the early 1980s in general. 
Besides cancer, smoking tobacco is the result of many serious diseases. For example, 
cigarette smoking leads to heart disease, stroke and chronic obstructive pulmonary disease 
(COPD or chronic bronchitis) (Boyle et al., 2004). Tobacco smoke exhaled by smokers, is 
usually in the environment. Smokers should bear a great responsibility for the harmful effects 
on those who inhale the smoke. This is a passive smoke and increases the risk of lung cancer 
(Boyle et al. 2003), as well as heart disease and respiratory disease. Passive smoke is especially 
harmful to young children. 
Smoking during pregnancy has important consequences for the offspring. This increases the 
risk of stillbirth, as it is associated with low birth weight of baby at birth. Also it has a great 
influence on subsequent mental and physical development of children. After birth, the both 
parents smoking increases the risk of the child's respiratory tract infections, causes of severe 
asthma and leads to sudden death (Boyle et al., 2004). 
Alcohol 
In the etiology of cancer the alcohol consumption also plays a huge role. The risk of cancer 
increases with the amount of alcohol consumption. Scientists have not established a limit of 
alcohol drinking (the safe level of alcohol consumption). But there is an evidence that people 
who use alcohol every day are more prone to cancer than people who only occasionally use 
alcohol. For example, men who consumed two or more servings of alcohol per day have an 
increased risk of developing cancer of the esophagus, mouth or throat. For women it is enough 
just one alcoholic drink per day to join a high-risk group. Women who drink alcohol are more 
prone to getting diseases such as liver cancer, breast cancer and colon cancer. (Poschl and Seitz 
2004; Boyle et al, 2003.). 
The WHO European Region, compared with the world or with other region WHO has the 
highest alcohol consumption per capita. This rate is two times higher than the world average. 
Drinking alcohol is the third most important risk factor that leads to many diseases in all age 
groups in the region. In the first and second risk factors leading to death are high blood pressure 
and smoking. Among young people the highest mortality associated with excessive alcohol 
consumption. The index acquisition-related diseases alcohol consumption in Europe is twice the 
global average (WHO 2006). According to the Eurobarometer in relation to alcohol 
consumption (March 2007) reported that 75% of EU citizens say that they drank alcohol within 
the past 12 months. On the basis of statistical data, we can conclude that there is an increase in 
alcohol consumption, which is observed in all EU countries since 2003 (European Commission 
2007). 
Even if a person does not smoke and only drinks, alcohol consumption increases the risk of 
cancer of the respiratory tract and upper digestive tract. When a person smokes and drinks, the 
risk of cancer increases exponentially (Boyle et al., 2003). 
80 
Askhat Ashimov: Trends and patterns of cancer mortality in Kazakhstan in comparison with 
some selected European countries from 1986 to 2008 
In addition to the above mentioned reasons, alcohol is also a major risk factor for other 
causes of death. In the EU among young people trauma (eg injured during leisure activities, 
traffic safety injury) is the leading cause of death (Petridou et al., 2007). Trauma is one of the 
main effects of alcohol. 
In addition, the negative impact of alcohol can be during pregnancy. A small dose of alcohol 
has a negative effect on the central nervous system of the fetus and its development, which often 
leads to cognitive impairment in the postpartum period, to congenital malformations, and 
violation of the child's behavior. Alcohol can also cause cardiovascular disease, although it is 
more dependent on the dose of alcohol for a long time (well-known J-shaped curve) (Cook and 
Reuter, 2007; Boyle et al, 2003). 
Diet and nutrition 
Scientists have suggested that about one-third (30-40%) of the total number of cancer deaths 
may be related to content of the diet. It is not yet confirmed, but the study of this field is 
developing very dynamically. Hardly a week goes all the new and new information about the 
risk of developing cancer in the case of holding of a bad diet and malnutrition (Divisi et al, 
2006;. Willett 2006). 
The first phase of the study was devoted to the determination of substances in connection 
with the consumption of fat, especially natural fat, on risk of developing cancer. Experimental 
studies and results of environmental investigations pointed to the very positive effects. 
However, the significant association between fat intake and the risk of developing breast or 
colorectal cancer based on the results of retrospective and prospective epidemiological studies 
in humans have not found (Boyle et al., 2003). 
Cereals high in fiber and whole grains have been determined on the basis of several 
European research as a way to reduce the risk of cancer of the gastrointestinal tract and 
colorectal cancer and other diseases. In order to confirm this theory, more researches are needed 
because not all of the results failed to re-obtain. (Willett 2006). 
In Southern European countries (eg Italy) the sickness and mortality from many type sof 
cancers is lower than in other regions of Europe. The reason for this is the Mediterranean food 
and a diet that includes food, rich in fish, olive oil, fruits and vegetables. All of these foods low 
in animal natural fats. Again, to confirm this theory it is important to have more studies (Martin-
Moreno 2000 Willett 2006). 
There have been many epidemiological studies on the fruits and vegetables. Studies have 
shown that some types of fruits and vegetables are useful for the prevention of cancer and 
various chronic diseases. It has been suggested that a diet rich in fruits and vegetables reduces 
the risk of various cancers, especially cancers of the pancreas, esophagus, colon, stomach, and 
rectum. These studies were conducted in many countries in Europe and North America, but the 
number of results is not sufficient for a complete statement of the theory. Eating fruits and 
vegetables has a protective effect for prevention of epithelial cancer and cancer of the 
respiratory tract and digestive organs. These studies are insufficient due to the fact that there 
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was not found a hormone that is influenced by fruit and vegetables to prevent the emergence 
and development of cancer. 
Fruits and vegetables as possible approaches to the prevention of cancer, contain a large 
number of potential anti-cancer elements. It is still unknown exactly what nutritional properties 
are effective against cancer. They are complementary and overlapping mechanisms of action. At 
present it is impossible to recommend vitamins against cancer, because the available data on the 
origin of cancer is not strong or specific enough. While there is no mineral and dietary 
supplements at the state level of health for the prevention of cancer (Willett 2006; Boyle et al, 
2003). 
Because of functional proteomics and new DNA chip technology i tis possible to understand 
more details in sphere of cancer dinase. 
As expected, research on the interaction of nutrients and cancer of the gene led to an 
understanding of the causes and consequences of cancer. This provided an understanding of the 
pathophysiological mechanisms and possible prevention of cancer. Through this research it 
became possible to better monitor the development of cancer, which is crucial to identify risky 
groups (Go et al, 2001; Willett 2006). 
Physical activity, obesity and body composition 
If a person regularly engaged in sports, then it reduces the risk of cancer. There are a few 
evidences that reduced the risk of colon cancer, breast cancer, prostate and uterus (the 
endometrium). Many believe that this effect is related to the magnitude of body weight and 
physical activity. Regular exercises, regardless of weight, have a preventive effect for some 
types of cancer (Boyle et al, 2003; Meltzer, Kaiser and Pichard 2004). 
Maintaining a healthy weight is important not only for the prevention of cancer, but also to 
reduce the risk of other chronic diseases such as diabetes and heart disease (Eyre, Kahn, and 
Robertson, 2004). cancer risk for obesity and overweight increases. For example, the disease 
can occur in the colon, in the breast (in postmenopausal women) in the esophagus, gall bladder, 
the uterus, kidneys and other organs. This is due to the fact that increases the production of 
estrogen and insulin, which leads to the negative effect caused by being overweight. Cancer 
cells may start to grow on the basis of these hormones (Ballard-Barbash et al, 2006; Boyle et al, 
2003). 
Obesity has now become one of the most common problem in the most European countries. 
There is a growing number of obese people. This issue has become a serious public health 
implications. In the WHO European Region from 30% to 80% of adults are overweight or 
obese. According to WHO, 2007, in print, about 20% of children and adolescents are 
overweight. In addition, one third of the children of the total number of children and adolescents 
are obese. This figure, as obesity is increasing rapidly. Scientists have suggested that in 2010, 
150 million adults and 15 million children will be obese. This problem is most dangerous 
among children and adolescents. In recent decades overweight and obesity among children is 
growing steadily and is now 10 times higher than a generation ago, in the 1970s. 
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On the basis of statistical data was calculated, what diseases are people suffering from 
obesity. 39% of the total number of people who are obese, have cancer of the endometrium, 
37% of people have cancer adenocarcinoma of the esophagus, 25% of kidney cancer, 24% of 
gallbladder cancers, 11% of colon cancer and 9% of breast cancer (Boyle et al ., 2003). The 
indicator on the distribution of calories in the body is a reflection of body fat distribution in the 
body and a penchant for thinness, or fatness. This factor may be more important than total 
energy consumption, for the risk kontrol of cancer. 
Occupational factors 
Professional environment as a cause of cancer was reported in 5% of cases. However, it 
underestimated the importance of exposure to carcinogenic risk factors in the workplace, as 
most work-related health (Boyle et al, 2003; Siemiatycki et al 2004). It is believed that the 
central problem of public health should be the issue of cancer research. 
The negative impact is usually manifested as malignant tumors. This kind of diseases can be 
found in the nasopharynx and larynx, bladder, lung, liver, nasal cavity. It may also manifest 
itself as skin cancer, leukemia, melanoma and mesothelioma. In addition to these there are other 
examples, but there is no clear justification. In this case, talking about cancer of the stomach, 
breast, oral cavity, colon and rectum, kidney, esophagus, prostate, pancreas, testes, bone and 
brain, as well as lymphoma, soft tissue sarcoma and multiple myeloma (Boyle et al , 2003; 
Siemiatycki et al 2004.). 
It was thought that in the EU around 23 % of employed people were exposed to dangerous 
for health and for life agents at levels above the accessibility. Basically, the impact of these 
factors is on the bottom level and does not harm human life, although this effect on people is 
widespread. These include passive smoking, radon, solar radiation, diesel exhaust, benzene, 
crystalline silica, asbestos, polycyclic aromatic hydrocarbons, wood dust, nickel compounds, 
formaldehyde, cadmium compounds, chromium (VI) (Boyle et al, 2003; Siemiatycki et al., 
2004). 
Air pollution and water contaminants 
There are several factors that are major characteristics of risk of air pollution: 1.3–butadiene and 
aldehydes; radon; combustion products such as radionuclides, polycyclic organic matter (POM), 
organic fibres (mainly asbestos), particulate matter; and residential proximity to industrial point 
sources (Samet and Cohen 2006). 
On the basis of this analysis we can conclude that the effect of carcinogens can be done both 
indoors and outdoors. This toxicological and epidemiological cause of human cancer. 
As the fine particles may be elements that pollute the air. The research results confirm that 
the spread of contaminants external environment of small particles can cause lung cancer, even 
at low levels of exposure. Thus, this effect may be subjected to a large number of subjects over 
long periods of time. According to statisticians, the rate of people with cancer due to this reason, 
in the EU remains very low, but important (Nawrot et al., 2007). 
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There is a theory of the concept as particulate matter (PM). These are particles that can 
consist of both solid and liquid of the organic or inorganic pollutants in the outside. These 
particles are in the most common way in the air. During the last decade, researches were carried 
out in many cities in the WHO European Region. These researches related to short-term 
exposure of these particles due to the constant and daily changes in concentrations (PM) on 
human health. Cases of death from lung cancer and cardiovascular diseases, which were the 
result of negative influence (PM) on human health (Anderson et al, 2004; WHO 2005). One of 
the main problems is the direction of health policy for additional research on factors affecting 
the development of lung cancer (Boyle et al, 2003; Samet and Cohen 2006). 
To confirm the above, let us turn to the consideration of drinking water. The composition of 
the water is carcinogenic substances at less than 100 parts per billion [g], which is a proven fact. 
Let’s consider a few contain carcinogenic substances: 
 inorganic arsenic (other trace metals are possible) – raises the following types of 
cancer as cancers of the bladder, non–melanoma skin cancer, kidney cancer and 
lung cancer; 
 organic synthetic chemicals (for example by–products disinfection) – raises the 
following types of cancer as cancers of the large bowel and the urinary bladder; 
 radium – raises the risk of osteosarcoma; 
 radon in water – raises the risk of lung cancer in case of extra-level of radon at home; 
 nitrate – raises the risk of different type sof cancers, especially gastrointestinal cancers. 
On the other hand, the presence of magnesium and calcium in the water, as well as the 
hardness of the water, provides protection against cancer in several places. 
Ionizing radiation 
There is a complex evidence of the association between high doses of ionizing radiation and 
cancer in humans (Boice 2006). 
The main source of ionizing radiation for people is the natural ground and cosmic radioation 
level.  However, the technical sources, such as nuclear power, nuclear accidents (e.g. Cherbyl), 
atmospheric nuclear testing and other impacts of comparison, give a much larger public interest. 
As the result of the atomic bomb survivors of Hiroshima and Nagasaki, the effects of high doses 
of ionizing radiation was well documented through the studies of that consequences. In 
medicine for therapeutic reasons (mainly radiotherapy for treating cancer) is used the high dose 
ionizing radiation. 
The United Nations Scientific Committee was established by a UN General Assembly 
resolution on the Effects of Atomic Radiation (NSCEAR) in 1955, in reply to broadly concerns 
of the effects of radiation on human health and the environment. For decades, UNSCEAR has 
become the world authority on influence of ionizing radiation (UNSCEAR 2007). 
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The population risk of dying from cancer after the impact to an urgent dose of 1000mSv 
(millisieverts) of ionizing radiation would be around 13% for women ans 9% for men, estimated 
by UNSCEAR.  
Exist the evidence that mammography screening programs significantly reduce the mortality 
of breast cancer. This advantage far outweighs the potential risk of cancer induced by radiation 
exposure during mammography. However, unnecessary influence of ionizing radiation must be 
avoided, although the collective exposition of diagnostic tests in comparing with natural 
radiation is small (Boyce, 2006. Boyle et al, 2003). 
Solar radiation 
Solar ultraviolet (UV) radiation is part of the electromagnetic spectrum of radiation 
emerging from the sun (Green and Whiteman 2006). Effect of sunlight is the environmental 
cause of skin cancer and ultraviolet radiation is a component of the solar spectrum involved. 
Those affected are mainly fair skin, especially people with red hair or with tendency to burn in 
the sun (Boyle et al., 2003). Three main types of skin cancer associated with the sun. The most 
common form of skin cancer amoung people who work outdoors is the squamous cell 
carcinoma which displays bright relationship with the cumulative sun influence. The recipients 
of transplanted organs have a high risk of these tumors by the combined influence of 
uncontrolled increase HPV in the skin (due to immune deficiency) and the sun. 
The most common type of skin cancer is the basal cell carcinoma; but its severity is limited, 
as this tumor is localized at the surface of the skin. This type of skin cancer, apparently shared 
etiological relation to being in the sun with melanoma. Finally, skin cancer, it seems, is 
associated with intermittent sun influence such as sunbathing and outdoor sports. The history of 
sunburn has repeatedly described as a risk factor. The incidence rates of skin cancer grew faster 
all over the world than any other malignancy in the Caucasian population in the last 30 years. 
Mortality continues to grow, despite the improved survival rates during this period (Hyblin and 
Thomas, 2007). 
In Europe, the incidence of melanoma has doubled between 1960 and 1990. This is due to 
the increase of intensive influence of the sun in the last century. The frequency of squamous cell 
carcinoma and basal cell cancer is also increased in above mentioned period in all European 
countries. These tumors are much less life threatening than melanoma, but they account for 95% 
of all skin cancers. Treatment is a significant financial burdens for people and the health system. 
Skin cancer remains an important task for cancer prevention and control (Hyblin and Thomas 
2007; Green and Whiteman 2006). 
Cancer screening and cure cancer 
The examination includes testing for disease in people without symptoms, with the main goal of 
lowering mortality from landing disease, in this case cancer. Further to its influence on life 
expectancy, screening also has other important implications, including the use of economic 
resources (as a rule, increase health care costs) and the implications for quality of life, both 
positive and negative. Cancer is always a potentially fatal disease, because the main purpose of 
85 
Askhat Ashimov: Trends and patterns of cancer mortality in Kazakhstan in comparison with 
some selected European countries from 1986 to 2008 
screening and treatment to save lives. Public policy of healthassociated with cancer screening 
has always taken, and their score in order to reduce mortality. Thus, the most important 
indicator of efficiency is mortality. 
Screening is suitable when the cancer  identify clinical stage during which it can be treated 
in order to prevent the progression of clear, clinically disease detactable (Cole and Morrison, 
1978). Opens clinical stage called the stay time (Day and Walter, 1984). Its length depends on 
the natural advance of disease, the absorption screening, available to diagnosis and 
characteristics of the screening test. 
The ideal screening program must reduce the burden of disease from the viewpoint 
mortality and morbidity, and / or improve quality of life. The screen detected breast cancers 
have a better prognosis than those detected clinically, since disease treated early. However, the 
selection will always have some side effects. Screen-identified cases often include boundary 
violations, some of them perform histological criteria for malignancy, but no progress, even if 
not treated, and will remain clinically slothful (Furihata and Maruchi 1969 Hugosson et al, 
2000;. MAIR, 2002; MAIR, 2005).  Any screening program reveal such violations as one of the 
adverse effects of screening are overdiagnosis, that slothful detection of disease, and useless of 
treatment (excess treatment). 
If the disease can be treated successfully after clinical diagnosis it was not necessary for 
verification. Screening should not be used for incurable diseases. 
In screening, primarily involving the goal of early invasive cancer. However, ductal 
carcinoma also found in 1/5 the frequency of invasive cancer. Mammography includes 
radiological pictures of the breast (one or two points of view) reading one or two radiologist. 
Screen-positive conclusion that the defeat is suspicious for breast cancer. Two views, most 
likely to increase the sensitivity by about 20%, with the largest increase in benefits for the 
identify of small cancers at women with thick breast tissue. Certain screening programs use two 
point of view to the first session and only one (mediolateraln oblique) the following screens. 
Double reading seems increase both the speed challenge and identify of breast cancer by 10%. 
Diagnostic evaluation demands the original biopsy or removal (open surgical) biopsy. 
Screening program conducted by or at the regional or national, including mechanisms for 
quality assurance for radiology and pathology services. Most application aimed at women in the 
age group 50-69, with two-year breaks between tests. A few northern European countries have 
achieved a 80% involvement and revocation rates of 1% to 8%. Prostate cancer has risen 
sharply over the past 10 to 15 years in the majority industrialized countries. In Europe, there 
were about 346.000 new cases of prostate cancer in 2004 (20% of all cancers) and nearly 87 000 
persons (9% of all cancer deaths) (Ferlay et al., 2007). 
Trust defeat for screening is the early invasive of prostate cancer, the diagnosis officially 
confirmed by prostate biopsy confirmed by prostate biopsy. The natural history of of prostate 
cancer varies greatly, and some very slothful, slow increasing tumors are others who are very 
aggressive. Precancerous injury like prostatic intraepithelial neoplasia (PIN), there are, but not 
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much predictive of developing prostate cancer. They are not considered indications for 
treatment. 
Prostate cancer is a hidden common section of finding: it was found in more than 10% of 
men dying before the age of 50 years, but more often than older men. Overall prostate cancer 
slothful clear indication of the possibility for overdiagnosis. 
The average time a key role in prostate cancer was evaluated in 6 to 12 years. Weather 
favorable, with a five-year relative survival rate of about 77% in Europe (Berrino et al., 2007). 
Over the past twenty years a lot of small parts has been accumulated about the main biological 
processes that are in violation of cancer. They include the key elements of a violation of growth 
factor mandatory, signal, control of gene transcription, checkpoints of the cell cycle, apoptosis 
and angiogenesis associated with disorganized growth of cancer cells (Sikora, 2002). They 
found fertile land for hunting rationally established antitumor preparations and developed a 
record number of new compounds currently in studies of cancer treatment. The number of such 
targeted preparations currently licensed for ordinary clinical practice, including rituximab, 
trastuzumab, imatinib, gefitinib, bevacizumab, lapatinib and cetuximab. Clearly, that will be 
noticeable the shift in the type of substances used in cancer treatment system over the next 
decade. It will impose enormous financial burden on all health care system. 
9.2 Proposal part – opportunities for cancer prevention  
In order to prevent oncological diseases (cancer), one should always consume foods rich in 
vitamin C (fresh fruit and vegetables), vitamin E (wheat sprouts), beta-carotene (all yellow fruit 
and vegetables, green leaves of vegetables and edible herbs), B- vitamins (beer yeast, which 
must be brewed before use) and mictroelements. It is necessary to remember about the 
importance of fiber (bran, oatmeal, buckwheat, wholemeal rye bread). Dietary supplements 
provide effective prevention from oncological diseases. Their efficacy has been proven by 
numerous positive results. Prevention of cancer is a complex of activities undertaken both on 
national and individual levels.  
One of the ways of cancer prevention is the elimination of air pollution by ensuring that 
industrial and residential smoke emissions remain under control. Switching the later to natural 
gas, central heating, changes in the regimen of coal burning, installing of modern smoke filters 
and further technical improvements can help clean the air. It is also of vital importance to 
construct industrial facilities outside the city limits in order to keep metropolitan air cleaner.  
The need for cleaning the air in urban areas from harmful substances is becoming more 
obvious. The quality of air can be improved by introducing more advanced methods of fuel 
combustion in a range of industrial enterprises along with automobile and aircraft engines. This 
should be accomplished by further advancement in engine construction and design, including 
thorough control of the technical state of the car enginges on the road.  
In case of cleaning the atmosphere, systematic government activities are required, whereas 
when it comes to smoking, in addition to prohibition of smoking in public places, the principles 
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of personal hygiene also come into effect. The surest way to prevention of lung cancer is 
complete abstinence from smoking. Teenage boys usually start smoking at the age of 14 to 17 in 
order to look more masculine and independent, whereas girls tend to take up smoking a little 
later on.  
The first step towards this harmful habit is usually made in attempt to copy the behaviour of 
their friends, as a way to manifest their masculinity and independence either before their friends 
or girlfriends.  The role of the family and school in prevention of smoking is unusually high. 
Personal example may be of great importance: children of smoking parents are very likely to 
take up the bad habit as well. 
If parents are interested in keeping their children away from smoking, they should lead by 
example and quit smoking, and create a non-smoking home environment. If a young person is 
brought up in a home with a friendly and healthy environment, is keen on sports, has a broad 
spectrum of interests and a rich leisure life, this leaves a very little chance for smoking.  
Adults who understand the harm of smoking with the help of willpower can overcome this 
addiction or at least dramatically cut down on the daily number of smoked cigarettes. This will 
significally reduce the harmful effect of cancerogenous substances on their organisms and may 
greatly deminish the risk of lung cancer.  
Thus healthy life style, regualr physical activities, timely and effective treatment of 
respiratory tract infections and absinence from smoking are considered to be reliable measures 
of prevention of chronic bronchitis and lung cancer.  
Unfortunately, all of the above mentioned steps may not fully guarantee that one will not get 
cancer. On the other hand, certain prevention activities and annual medical check-ups are 
capable of providing at least minimal prevention.  
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Conclusion 
The objective of this study was to give an image of Kazakhstan in the context of selected 
European countries in respect to life expectancy, cause–specific mortality and cancer sites in the 
period between 1986 until 2008. 
Cause–specific mortality levels data and population data of Kazakhstan covers the years 
between 1986-2008. The taken period was observed in the European countries levels in 
comparison to Kazakhstan, detailed cancer mortality analysis was performed.  
These observations argue for making oncological disease control a priority in the healthcare 
agenda. This will require the development of new managerial systems for cancer control that 
would facilitate policy and programmatic decisions that take full account for the 
costeffectiveness and affordability of interventions. 
Due to the fact that apart from Kazakhstan I have also analyzed other countries, I think that 
my thesis may be beneficial not just from Kazakhstan’s perspective, but also from the 
international one. The findings of my thesis may be used in both: medical and social spheres. I 
have answered all the questions that I raised in the beginning of my thesis. I have found out 
which types of cancer are the most dangerous ones and also how fast they spread, hence I have 
pointed out the trends.  
I consider all of the objectives of my thesis to have been fulfilled. I have examined cancer 
mortality rates across Kazakhstan in great detail. I have come to the conclusion that the 
characteristics of cancer vary significantly in many areas of Kazakhstan. My thesis is intended 
for a wide range of readers interested in progression of cancer.   
Kazakhstan can build on a number of strengths, including the well–established National 
Institute of Oncology and the population–based Cancer Registry, covering the entire country. 
Yet, while many cancer control activities have been in place for many years, there is still much 
room for improvement, and in particular the need to develop a comprehensive national cancer 
control programme that would incorporate clearly defined goals and objectives, responsibilities, 
financial support, adequate training and ongoing audit and quality control. 
This master thesis has illustrated the many different challenges in terms of health and health 
threats selected countries of Central and Eastern Europe and the former Soviet Union are 
currently facing. 
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It has shown that several countries especially in Central and Eastern Europe have fared 
rather successfully and are experiencing sustained improvements in general health indicators 
such as life expectancy. This review has shown that there is still a substantial unfinished agenda 
in terms of public health in this region. While much has been achieved in many spheres, there is 
still some way to go to achieve the levels of health enjoyed in Western Europe. Moreover, new 
threats, in particular HIV and resistant tuberculosis and the predations of the global tobacco 
industry, are apparent. 
Tackling these problems requires the development of a strong public health capacity in this 
region that is prepared and equipped to address supranational health threats including trade of 
products damaging to health if threats to health are to be curtailed. In all of these settings a new 
generation of strong and effective leaders who can be advocates for healthy public policies is 
clearly needed.  
This calls for particular skills and in some countries the move towards greater democracy 
and political freedom. However, the often–cited solution, retraining, has been of only moderate 
success and, regrettably, it has often been necessary to accept that some changes may take a 
generation to unfold. This means engaging with governments and international agencies in order 
to change the agenda so that public health is seen as a priority. 
Annually, more than 28,000 cases of cancer are identified in the Republic of Kazakhstan. 
There were about 28.330 new diagnoses of cancer in 2008. Disease incidence is 180.7 per 
100.000. Currently, there are approximately 134.000 patients registered in oncology 
establishments. 
In recent years, the north–east regions of the country have been identified as high–incidence 
areas. Malignancy rates in this area have exceeded the average indicators in the country for 
many years. The increased cancer rates are connected to adverse events which occurred in the 
country at the former Semipalatinsk nuclear polygon used as a site for Soviet Union’s atomic 
bomb project. Over 400 atmospheric, above ground and underground nuclear and hydrogen 
explosions have been conducted here between 1949 to 1989.  
There are now special medical programs to help rehabilitate the people who have developed 
ailments due to the nuclear tests conducted in the area. The northern area and the city of Almaty 
represent a large megapolis and follow the above-mentioned region using data on the frequency 
of oncological tumors. The high density of the industrial zones adversely influences the 
environment which in turn affects factors that promote cancer in these regions. 
53.5 % of all cancer cases in the country occur in females. There are more than 50 different 
kinds of cancer, but some of them–lung, breast, stomach, esophagus, colorectal–represent over 
half of all new cases. 
Annually, more than 4,000 people develop lung cancer in Kazakhstan. Unfortunately, only 
20 % of all are diagnosed in the early stages, which accounts for the high mortality rate. The 
statistical analysis has showed slow growth of survival rates over the last years. 
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Cigarette smoking has been identified as the most important preventable cause of mortality 
in the country. Laws on prohibition of smoking in public places were implemented in 2009, 
which will hopefully result in a decrease of lung cancer cases in future. 
Currently, the most important factors affecting health are insufficient physical activity, poor 
diet, smoking, alcohol consumption, unhealthy lifestyle, intolerance to stress, and, 
unfortunately, delaying visits to specialists. Worsening environmental conditions in the rapidly 
developing country continue to impact the health of young generations. The above–mentioned 
factors affect the cancer incidence in the country and are the main reasons for the expected 
growth of cancer incidence. 
Every year, in the Republic of Kazakhstan there are registered more than 28.000 cases of 
cancer. In 2008, there were over 28.330 new diagnoses of this disease. Moreover, the disease 
rate is 180.7 per 100.000. At the moment, there are about 134.000 patients listed in oncology 
hospitals. 
It must be mentioned, that in the last few years, the north–east areas of the country have 
been determined as high–incidence regions. The medium markers of malignancy in the country 
have been overpast a lot in comparison with many years. The cancer rates have rised due to 
facts that took place at the ex-Semipalatinsk nuclear polygon exploited as a location for Soviet 
Union’s atomic bomb plan, in the country. For more than 40 years, 1949 to 1989, there were 
doner over 400 atmospheric, nuclear and hydrogen explosions above ground and underground. 
In order to improve the situation and help people, were made special medical programs to 
help people who developed many diseases and suffer because of the nuclear tests lead in the 
region. This medical programs help people to rehabilitate. According to the kept data about 
oncology tumors, Almaty and the norhten area represent a large region were the mentioned 
disease is very frequent. It is clear that it is caused by the industrial zones which density is very 
high and it influences negatively the environment. The environment as a result affects factors 
that provokes cancer in mentioned areas. 
It really makes us worry about that fact that 53.5 % of all cancer incidents in the country are 
found in females. We have to know that, more than 50 different kinds of cancer exist, but the 
most frequent are: lung, breast, stomach, esophagus, colorectal. 
The number of more than 4.000 people that have lung cancer every year in Kazakhstan, is 
frightening but this is the reality. It is very important the patiant to be diagnosed in first stages, 
but it happens to only 20 % of all, and it accounts for the high mortality rate. Fortunately, not 
everythign is so bad, and the good news is that during the last years the number of survided 
people grew slowly. It is demonstrated by an statistical analysis. 
The worst and the most important thing identified is the cigarette smoking. Therefore, in 
2009, there were implemented laws on smoking in public places. We realy hope that this will 
work and the cases of lung cancer will decrease.  
Besides smoking, there are also other important agents that affect the health and which must 
be enumarated: improper diet, stress, alcohol consumption, no physical activity, and of course 
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delaying visits to doctors. An impact is also the fact that the conditions of the environment of 
the country is worsening day by day, thus influencing the next generations. All pointed factors 
represent the main causes for an expected growth of cancer incidence in the country, but if they 
will be worked out the cancer rate can be decreased. 
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Appendix 1: Life expectancy in selected European countries, Kazakhstan and the Russian Federation, selected years 











at birth Males 67,5 67,6 70,4 71,7 73,4 6,0 5,9 3,1 1,8 
  
Females 74,7 75,5 77,4 78,5 79,9 5,2 4,4 2,4 1,4 
  
Differences 7,2 7,9 7,1 6,8 6,4 
    
 
Life expectancy 
at age 65 Males 11,5 11,7 13,1 13,8 14,8 3,3 3,2 1,7 1,1 
  
Females 14,8 15,3 16,6 17,3 18,3 3,5 2,9 1,7 1,0 
  
Differences 3,3 3,7 3,4 3,5 3,4 
    
            











at birth Males 71,7 73,3 74,7 75,4 77,4 5,6 4,0 2,6 2,0 
  
Females 79,9 81,7 82,7 83,0 84,4 4,5 2,7 1,7 1,4 
  
Differences 8,2 8,4 8,0 7,6 7,0 
    
 
Life expectancy 
at age 65 Males 14,6 16,0 16,6 16,8 18,2 3,6 2,2 1,6 1,4 
  
Females 19,1 20,6 21,3 21,4 22,6 3,5 2,0 1,3 1,2 
  
Differences 4,5 4,6 4,7 4,6 4,4 
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Appendix 1: continued 











at birth Males 65,3 65,1 66,3 67,1 69,2 3,9 4,0 2,9 2,0 
  
Females 73,3 73,8 75,0 75,7 77,7 4,4 3,9 2,7 2,0 
  
Differences 8,0 8,6 8,7 8,6 8,5 
    
 
Life expectancy 
at age 65 Males 11,9 12,1 12,3 12,6 13,6 1,7 1,6 1,3 1,1 
  
Females 15,0 15,4 15,9 16,4 17,7 2,6 2,3 1,7 1,3 
  
Differences 3,1 3,3 3,6 3,8 4,0 
    
            











at birth Males 72,6 73,7 75,2 76,5 78,5 5,8 4,8 3,3 2,0 
  
Females 79,2 80,4 81,5 82,5 84,2 5,0 3,8 2,6 1,6 
  
Differences 6,5 6,7 6,4 6,0 5,7 
    
 
Life expectancy 
at age 65 Males 14,3 15,0 15,9 16,5 17,9 3,6 2,8 1,9 1,3 
  
Females 18,1 19,0 20,0 20,5 21,8 3,7 2,8 1,8 1,3 
  
Differences 3,8 3,9 4,1 4,0 3,9 
    











at birth Males 64,2 63,8 58,8 60,0 60,6 -3,6 -3,2 1,8 0,5 
  
Females 73,0 73,3 70,2 71,5 71,9 -1,1 -1,4 1,7 0,4 
  
Differences 8,9 9,5 11,4 11,5 11,4 
    
 
Life expectancy 
at age 65 Males 12,6 12,5 10,7 10,5 11,3 -1,3 -1,2 0,6 0,8 
  
Females 16,6 16,4 14,6 15,1 15,0 -1,5 -1,3 0,4 -0,1 
  
Differences 3,9 3,9 3,9 4,6 3,7 
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at birth Males 72,8 73,4 75,4 75,9 78,2 5,4 4,8 2,8 2,3 
  
Females 79,9 79,9 81,1 81,4 82,8 2,9 2,9 1,7 1,4 
  
Differences 7,0 6,5 5,8 5,5 4,6 
    
 
Life expectancy 
at age 65 Males 14,5 14,6 15,5 16,1 17,6 3,1 3,0 2,1 1,5 
  
Females 18,9 18,7 19,6 19,8 20,8 1,9 2,1 1,2 1,0 
  
Differences 4,4 4,1 4,1 3,7 3,2 
    
            Russian 











at birth Males 64,8 63,7 59,6 59,0 60,3 -4,5 -3,4 0,7 1,3 
  
Females 74,3 74,3 72,4 72,3 73,2 -1,1 -1,2 0,7 0,9 
  
Differences 9,5 10,6 12,8 13,2 12,8 
    
 
Life expectancy 
at age 65 Males 12,1 12,0 11,3 11,1 11,4 -0,6 -0,6 0,1 0,4 
  
Females 15,8 15,8 15,2 15,1 15,6 -0,2 -0,2 0,4 0,5 
  
Differences 3,7 3,8 3,9 4,1 4,2 
    











at birth Males 74,0 74,8 76,6 77,4 78,7 4,7 3,9 2,1 1,4 
  
Females 80,1 80,5 81,7 82,1 83,0 2,8 2,5 1,3 0,9 
  
Differences 6,2 5,7 5,1 4,7 4,3 
    
 
Life expectancy 
at age 65 Males 14,8 15,3 16,1 16,7 17,7 2,8 2,3 1,5 1,0 
  
Females 18,9 19,2 19,9 20,2 20,8 1,9 1,6 0,9 0,6 
  
Differences 4,0 3,8 3,7 3,5 3,1 
    Source: Author’s own calculations based on data from WHO mortality database 
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Appendix 2: Mortality caused by all causes in selected years, females, standardized death rates (per 100 000 
persons, WHO European Population Standard) 
  Males 
Countries All causes Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 1590.6 1268.8 1024.1 80 64 81 
France 1102.3 864.6 715.2 78 65 83 
Hungary 1653.5 1581.3 1316.6 96 80 83 
Italy 1066.0 860.8 668.9 81 63 78 
Kazakhstan 1550.5 2159.2 1971.1 139 127 91 
Norway 1036.8 880.5 686.1 85 66 78 
Russian Federation 1622.1 2028.9 1997.3 125 123 98 
Sweden 973.0 806.4 666.9 83 69 83 
  Females 
Countries All causes Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 953.9 750.1 613.2 79 64 82 
France 579.2 452.4 394.6 78 68 87 
Hungary 985.8 880.8 714.7 89 73 81 
Italy 629.1 505.9 401.9 80 64 79 
Kazakhstan 887.8 1122.3 1055.6 126 119 94 
Norway 587.8 534.7 459.2 91 78 86 
Russian Federation 895.2 1009.5 976.8 113 109 97 
Sweden 579.5 509.0 451.9 88 78 89 
Source: Author’s own calculations based on data from WHO mortality database 
Appendix 3: Mortality caused by infectious diseases in selected years, males, females, standardized death rates (per 
100 000 persons, WHO European Population Standard) 
  Males 
Countries Infectious diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 5.8 3.4 4.3 59 74 126 
France 13.3 11.1 13.6 83 103 123 
Hungary 14.2 11.3 5.5 80 39 49 
Italy 5.5 4.6 10.1 84 185 221 
Kazakhstan 44.4 91.8 44.0 207 99 48 
Norway 6.3 9.2 11.3 146 180 124 
Russian Federation 24.7 40.0 40.9 162 166 102 
Sweden 6.0 6.1 9.4 102 156 153 
  Females 
Countries Infectious diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 3.8 1.5 2.7 39 70 181 
France 8.0 6.5 7.6 81 94 117 
Hungary 5.1 3.5 2.0 69 40 58 
Italy 3.0 2.8 5.6 92 186 203 
Kazakhstan 19.8 21.6 13.0 109 66 60 
Norway 4.3 5.0 7.7 116 177 153 
Russian Federation 7.7 7.5 9.7 98 126 129 
Sweden 5.1 4.4 6.7 86 132 152 
Source: Author’s own calculations based on data from WHO mortality database 
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Appendix 4: Mortality caused by neoplasm diseases in selected years, males, females, standardized death rates (per 
100 000 persons, WHO European Population Standard) 
  Males 
Countries Neoplasm diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 353.4 338.6 286.8 96 81 85 
France 322.1 286.1 251.1 89 78 88 
Hungary 349.5 394.3 348.4 113 100 88 
Italy 289.5 273.0 233.2 94 81 85 
Kazakhstan 310.7 292.6 229.5 94 74 78 
Norway 230.6 233.4 200.7 101 87 86 
Russian Federation 306.6 299.7 267.9 98 87 89 
Sweden 201.5 195.1 183.5 97 91 94 
  Females 
Countries Neoplasm diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 190.9 179.8 164.9 94 86 92 
France 140.7 129.6 125.2 92 89 97 
Hungary 192.5 203.2 178.8 106 93 88 
Italy 148.9 143.6 128.0 96 86 89 
Kazakhstan 154.4 147.0 128.5 95 83 87 
Norway 153.2 162.4 141.1 106 92 87 
Russian Federation 139.4 139.7 132.6 100 95 95 
Sweden 147.3 144.8 139.2 98 94 96 
Source: Author’s own calculations based on data from WHO mortality database 
Appendix 5: Mortality caused by circulatory diseases in selected years, males, females, standardized death rates 
(per 100 000 persons, WHO European Population Standard) 
  Males 
Countries Circulatory diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 848.5 666.3 477.8 79 56 72 
France 348.6 239.0 174.3 69 50 73 
Hungary 820.2 738.4 590.7 90 72 80 
Italy 439.8 328.1 225.4 75 51 69 
Kazakhstan 727.5 1064.6 1068.8 146 147 100 
Norway 498.2 374.5 221.8 75 45 59 
Russian 
Federation 877.1 987.0 1044.5 113 119 106 
Sweden 510.8 377.1 261.9 74 51 69 
  Females 
Countries Circulatory diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 549.2 430.6 318.2 78 58 74 
France 205.4 138.1 102.1 67 50 74 
Hungary 549.2 477.0 366.4 87 67 77 
Italy 294.4 215.7 151.0 73 51 70 
Kazakhstan 496.1 658.8 658.9 133 133 100 
Norway 258.5 208.5 144.3 81 56 69 
Russian 
Federation 588.6 606.4 606.4 103 103 100 
Sweden 287.7 217.4 162.9 76 57 75 
Source: Author’s own calculations based on data from WHO mortality database 
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Appendix 6: Mortality caused by respirátory diseases in selected years, males, females, standardized death rates 
(per 100 000 persons, WHO European Population Standard) 
  Males 
Countries Respiratory diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 103.5 56.5 60.1 55 58 106 
France 79.1 65.3 39.3 83 50 60 
Hungary 103.8 78.2 70.1 75 68 90 
Italy 89.8 57.8 45.1 64 50 78 
Kazakhstan 185.5 213.0 124.5 115 67 58 
Norway 80.4 71.5 62.6 89 78 88 
Russian Federation 123.1 129.3 101.2 105 82 78 
Sweden 76.4 63.9 38.4 84 50 60 
  Females 
Countries Respiratory diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 48.4 29.1 30.2 60 62 104 
France 35.0 29.9 18.2 86 52 61 
Hungary 41.7 32.7 29.0 78 69 89 
Italy 35.4 21.3 18.5 60 52 87 
Kazakhstan 85.5 80.6 40.9 94 48 51 
Norway 50.0 44.6 39.8 89 80 89 
Russian Federation 44.1 34.3 24.4 78 55 71 
Sweden 41.5 37.2 25.3 90 61 68 
Source: Author’s own calculations based on data from WHO mortality database 
Appendix 7: Mortality caused by digestive diseases in selected years, males, females, standardized death rates (per 
100 000 persons, WHO European Population Standard) 
  Males 
Countries Digestive diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 63.4 49.5 48.5 78 77 98 
France 66.3 45.0 31.9 68 48 71 
Hungary 101.4 134.2 106.0 132 105 79 
Italy 67.6 42.3 27.4 63 41 65 
Kazakhstan 57.6 75.8 91.4 132 159 121 
Norway 29.1 24.5 17.5 84 60 71 
Russian Federation 44.1 62.8 81.9 142 186 130 
Sweden 26.8 25.9 21.7 97 81 84 
  Females 
Countries Digestive diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 30.1 23.8 25.2 79 84 106 
France 32.5 23.7 16.2 73 50 68 
Hungary 48.0 51.2 42.8 107 89 83 
Italy 31.0 23.9 15.9 77 51 66 
Kazakhstan 31.8 36.8 43.3 116 136 118 
Norway 18.1 14.0 13.4 78 74 96 
Russian Federation 20.9 27.7 40.9 133 196 148 
Sweden 14.8 16.0 13.6 108 92 85 
Source: Author’s own calculations based on data from WHO mortality database 
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Appendix 8: Mortality caused by external diseases in selected years, males, females, standardized death rates (per 
100 000 persons, WHO European Population Standard) 
  Males 
Countries External diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 109.7 99.5 78.1 91 71 78 
France 112.7 86.5 66.6 77 59 77 
Hungary 167.5 141.5 103.5 84 62 73 
Italy 63.9 54.4 43.1 85 68 79 
Kazakhstan 98.0 275.6 263.4 281 269 96 
Norway 79.2 57.5 57.2 73 72 99 
Russian Federation 174.4 354.0 317.5 203 182 90 
Sweden 75.3 54.6 53.4 73 71 98 
  Females 
Countries External diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 58.9 42.4 25.5 72 43 60 
France 50.8 37.5 27.7 74 55 74 
Hungary 73.1 54.5 31.7 75 43 58 
Italy 27.5 23.4 16.0 85 58 69 
Kazakhstan 33.1 72.8 66.8 220 202 92 
Norway 33.5 26.3 25.4 78 76 97 
Russian Federation 48.1 84.3 75.4 175 157 89 
Sweden 30.1 23.8 22.8 79 76 96 
Source: Author’s own calculations based on data from WHO mortality database 
Appendix 9: Mortality caused by others diseases in selected years, males, females, standardized death rates (per 
100 000 persons, WHO European Population Standard) 
  Males 
Countries Others diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 106.3 54.9 68.6 52 65 125 
France 160.2 131.6 138.3 82 86 105 
Hungary 96.9 83.5 92.4 86 95 111 
Italy 109.9 100.6 84.4 92 77 84 
Kazakhstan 126.8 145.9 149.4 115 118 102 
Norway 113.0 110.0 115.0 97 102 105 
Russian Federation 72.1 156.1 143.5 217 199 92 
Sweden 76.1 83.7 98.5 110 129 118 
  Females 
Countries Others diseases Index (%) 
  1986 1996 2006 1996/1986 2006/1986 2006/1996 
Czech Republic 72.7 42.9 46.6 59 64 109 
France 106.8 87.2 97.6 82 91 112 
Hungary 76.3 58.7 64.0 77 84 109 
Italy 88.9 75.2 66.9 85 75 89 
Kazakhstan 67.0 104.6 104.2 156 155 100 
Norway 70.2 74.0 87.5 105 125 118 
Russian Federation 46.4 109.5 87.3 236 188 80 
Sweden 52.9 65.5 81.4 124 154 124 
Source: Author’s own calculations based on data from WHO mortality database 
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Appendix 10: The structure of cancer mortality by the leading sites of neoplasm, the Czech Republic, selected 
years, males 
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Appendix 12: The structure of cancer mortality by the leading sites of neoplasm, France, selected years, males 
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Appendix 14: The structure of cancer mortality by the leading sites of neoplasm, Hungary, selected years, males 
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Appendix 16: The structure of cancer mortality by the leading sites of neoplasm, Italy, selected years, males 
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Appendix 18: The structure of cancer mortality by the leading sites of neoplasm, Kazakhstan, selected years, males 
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Appendix 20: The structure of cancer mortality by the leading sites of neoplasm, Norway, selected years, males 
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Appendix 24: The structure of cancer mortality by the leading sites of neoplasm, Sweden, selected years, males 
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Apendix 26: The potential years of life lost (YPLL) for selected countries, males, females, 2006 
 
 
Appendix27: Aging index of all countries, selected years of the period 1986-2006, males 
 
Source: Author’s own calculations based on data from WHO mortality database 
Appendix28: Aging index of all countries, selected years of the period 1986-2006, females 
 
Source: Author’s own calculations based on data from WHO mortality database 
Countries
All causes Infectious Neoplasm Circulatory Respiratory Digestive External Others
Czech Republic 95.4 0.5 27.0 26.2 3.9 7.3 20.8 9.7
France 73.4 1.6 23.9 9.9 1.6 3.8 15.9 16.8
Hungary 150.8 1.0 40.8 43.1 6.0 18.6 26.6 14.8
Italy 58.6 1.6 20.4 11.6 1.4 2.9 11.3 9.4
Kazakhstan 260.7 13.6 18.0 70.2 15.4 14.9 89.1 39.4
Norway 56.3 0.7 14.1 10.6 1.7 1.2 15.1 12.9
Russian Federation 302.5 13.3 27.4 91.0 15.0 16.9 107.5 31.4
Sweden 53.0 0.7 14.1 12.3 1.5 2.2 12.4 9.8
Causes of death (males)
Countries
All causes Infectious Neoplasm Circulatory Respiratory Digestive External Others
Czech Republic 44.9 0.2 18.9 10.5 1.6 3.0 5.1 5.6
France 35.0 0.7 14.4 3.6 0.7 1.5 5.0 8.9
Hungary 67.1 0.3 24.3 17.3 2.8 6.9 6.3 9.2
Italy 30.6 0.7 14.9 4.6 0.6 1.2 2.7 5.9
Kazakhstan 109.9 5.1 15.0 30.2 7.1 6.8 22.6 23.1
Norway 33.6 0.4 14.3 4.1 1.4 0.9 5.1 7.4
Russian Federation 106.5 3.4 18.9 34.5 4.2 8.1 23.3 14.1
Sweden 33.8 0.4 15.0 5.0 1.0 1.1 4.8 6.3
Causes of death (females)
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